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ABSTRACT
 
PhD thesis – Andrea Zaniboni, 2015 
2 
 
Since the publication of the book of Russell and Burch in 1959, scientific research 
has never stopped improving itself with regard to the important issue of animal 
experimentation. 
The European Directive 2010/63/EU “On the protection of animals used for 
scientific purposes” focuses mainly on the animal welfare, fixing the Russell and 
Burch’s 3Rs principles as the foundations of the document. In particular, the 
legislator clearly states the responsibility of the scientific community to improve the 
number of alternative methods to animal experimentation. 
The swine is considered a species of relevant interest for translational research and 
medicine due to its biological similarities with humans. The surgical community has, 
in fact, recognized the swine as an excellent model replicating the human 
cardiovascular system. 
There have been several wild-type and transgenic porcine models which were 
produced for biomedicine and translational research. Among these, the 
cardiovascular ones are the most represented. 
The continuous involvement of the porcine animal model in the biomedical research, 
as the continuous advances achieved using swine in translational medicine, support 
the need for alternative methods to animal experimentation involving pigs. 
The main purpose of the present work was to develop and characterize novel porcine 
alternative methods for cardiovascular translational biology/medicine. 
The work was mainly based on two different models: the first consisted in an ex vivo 
culture of porcine aortic cylinders and the second consisted in an in vitro culture of 
porcine aortic derived progenitor cells. Both the models were properly characterized 
and results indicated that they could be useful to the study of vascular biology. 
Nevertheless, both the models aim to reduce the use of experimental animals and to 
refine animal based-trials. 
In conclusion, the present research aims to be a small, but significant, contribution to 
the important and necessary field of study of alternative methods to animal 
experimentation. 
 
Key words: Porcine Animal Model, Alternative Methods, 3Rs, Mesenchymal 
Stromal Cells, Perivascular Cells, Vascular Biology 
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Alternatives to Animal Testing: from the 3Rs of Russell & Burch to 
the European Directive 2010/63/EU 
 
Alternatives to animal testing are an important and essential tool for scientists from 
all over the world that need to go toward a continuous process of development and 
implementation. 
 
According to its standard definition “animal testing” is intended as “the use of 
animals in experiments and development projects usually to determine toxicity, 
dosing and efficacy of test drugs before proceeding to human clinical trials”. 
 
In a wider meaning, the phrase “alternatives to animal testing” is used by the 
scientific community to indicate the possibility to develop alternative methods to 
animal experimentation. 
 
It is clear that animal testing cannot be reduced to the mere use of animal in studying 
the pharmacokinetics and pharmacodynamics of drugs. There is a huge number of 
scientific papers in the literature describing the use of laboratory animals to study 
physiology, pathology and pathogenesis of human and animal diseases (McGonigle 
& Ruggeri, 2014). 
 
Russell and Burch were the first who drafted the basic principles concerning the use 
of animals in scientific experiments in their book “The Principles of Humane 
Experimental Technique”. The authors described the amazing growth of biological 
sciences after the Darwin Revolution and the vast number of animals used for 
experimentation in human and veterinary medicine and in basic sciences. Overall, the 
authors underlined within the aim of their work that “the humanest possible 
treatment of experimental animals (…) is actually a prerequisite for successful 
animal experiments” (Russell and Burch, 1959), unifying, for the first time, animals 
rights and researchers main goal.  
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The main inheritance that Russell and Burch’s work left to the scientific community 
was, indeed, the so-called 3Rs: Replacement, Reduction and Refinement. 
 
The term Replacement refers to the possibility of using any scientific method that 
does not employ animals to reach the same results that were reached using conscious 
living vertebrates. If an alternative exists, researchers are not ethically allowed to use 
animal in their experiments. 
The term Reduction refers to a meticulous and continuous activity leading to the 
reduction of experimental animals numbers (whenever they cannot be Replaced), in 
order to achieve the same results with different means. The reduction is described as 
“the one most obviously, immediately, and universally advantageous of all modes of 
progress in terms of efficiency”. 
Lastly, the term Refinement refers to the detailed study of animal experimentation in 
order to choose the right procedures and the right species for the experiments, and in 
order to minimize animals stress and pain. This final stage, in fact, aspires to look for 
the continuous enhancement of the animal wellness (Russell & Burch, 1959). 
 
Since the publication of the book of Russell and Burch in 1959 the research in the 
3Rs field has never stopped improving itself with regard to the important issue on 
animal experimentation Over the past 40 years the Russell and Burch’s 3Rs have 
commonly been accepted as ethical guidelines and as milestones for all the animal-
based studies, in many countries all over the world (Forni, 2007; Singh, 2012). 
 
In this regard, the commitment taken by the scientists attending the 2010 “First Basel 
Conference” is of major importance. The same commitment was, then, formalized 
into the Basel Declaration and signed by many other scholars all over the world 
through its web page (http://www.basel-declaration.org). This document states that 
modern science still needs to use animals in order to study physiology, pathology and 
pathogenesis of diseases and to improve veterinary approaches. Nonetheless, some 
fundamental principles should be observed. Surely, the 3Rs prove to be the kind of 
ethical principles the scientific community is looking for, whose main goal is the 
respect for all the animals used for experimental purposes, trying to avoid them pain 
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and useless suffering. Moreover, the declaration encourages collaboration among 
scientists, in order to avoid repeating futile animal-based experiments, as well as the 
education of the people involved in animal experiments. Finally, with the declaration 
it is stated that necessary research involving animals have to be allowed in the future 
and it is asked to encourage the public discussion of sensitive issues concerning 
research involving animal (Basel Declaration, 2010). 
 
Right now, animal models are considered the major source of biological and 
physiological information, a precious system for drug discovery and, consequently, 
of utmost importance as a translational tool in most of the major human diseases 
(Wendler & Wehling, 2010). 
 
Despite the progress in animal experimentation procedures, the ethical acceptance of 
animal models for the study of human diseases and, eventually, their treatment is still 
into focus. Animal testing, in fact, has always been one of the main actors in the 
international scientific arena. Concerning it, one of the key questions is the validation 
of the model in term of transferability to the human species (Dothel et al., 2013). 
 
The translation of theoretical knowledge and experimental breakthroughs into 
clinical practice of medicine is also known as Translational Medicine. Obviously, 
scientific discoveries prove to be complete when they result into an application: 
usually, a medical discovery follows the path, from the “benchside to the bedside” 
resulting in the so called Translational Research (Keramaris et al., 2008). Animal 
testing places itself exactly in the middle of the process of the Translational Research 
applied to the study of human biology. 
 
Evidently, the best model to study human biology (physiology, pathology, treatment 
of diseases) would be the human subject, but it is clear that this option can not be 
considered ethical. To overcome this problem, animals have been routinely used as 
models to characterize pathogenesis of diseases and to discover new drugs, entailing 
several advantages such as the homogeneity of the population and the wider 
possibilities to study toxicity of treatments, pathology and physiology. The 
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evaluation of mechanism of action of existing drugs and the discovery of new drugs 
have been widely carried out using animal models. However, even if the animal is a 
complex and functional model, effective treatments on animals could be less or not 
effective or, sometimes, even harmful on humans (Hooijmans & Ritskes-Hoitinga, 
2013; McGonigle & Ruggeri, 2014). The main challenges in Translational Research 
consist in the biological differences among species, the poor methodological quality 
of animal experiments, the differences in designing the experiments that involve 
animals, as well as the deficient reporting of the details concerning the animal 
experimentation (Hooijmans & Ritskes-Hoitinga, 2013). 
 
Scientists are always committing to the continuous challenge faced by the 
translational research involving animal experiments. In 2002 the LANCET journal 
reported the article “Systematic reviews of animal experiments” written by 
Sandercock and Roberts. This paper strongly recommended the systematic review of 
the literature concerning well performed animal experiments (high quality 
methodology) as the base of any new clinical trial (Sandercock & Roberts, 2002). It 
is quite clear that the high quality methodology (Russell and Burck’s Refinement) is 
essential to improve the outcome of a translational research. 
The urgent need for guidelines in animal experiments was also underlined in the 
Kilkenny and colleagues paper. After a survey on a consistent number of scientific 
papers concerning animal testing, the authors reported a lack of some of the major 
information about the experiments that involve animals and recommend an accurate 
and transparent description of the methods (Kilkenny et al., 2009). In their following 
articles, they also defined the Animal Research Reporting In Vivo Experiments 
(ARRIVE) guidelines as a tool for animal-based experimentation (Kilkenny and 
colleagues, 2010 and 2012; Hooijmans & Ritskes-Hoitinga, 2013; Dothel et al., 
2013), available on the web (https://www.nc3rs.org.uk/arrive-guidelines) and 
actually required by many relevant biological journals for publications of animal 
experiments. 
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Despite the enormous efforts that many scientists did in the last decades, the current 
debate focuses mainly on the question: are preclinical studies in animals still 
ethically acceptable (Dothel et al., 2013)? 
 
Unfortunately, the present question requires more than a simple answer. As the topic 
is of clear interest, not only for the scientific community but also for those who do 
not belong to it, a specific legislation about animal protection is necessary. 
 
In Europe, the previous Directive of the European Commission in the field regarding 
the animal protection was released on 24 November 1986 (Directive 86/609/EEC). 
Its adoption, nonetheless, varied according the different Member States. Some of 
them, for instance, implemented it with measures to ensure higher level of protection 
for the animal used for experimental purposes. However, these disparities within 
Member States have been considered a possible barrier for the exchange of products 
and substances that involve animal-based trials. 
Moreover, since 1986, new scientific data have been collected, new technological 
approaches have been used and new evidences updated the knowledge about animal 
welfare and the capacity of animals to express pain, suffering and distress. 
Considering these and other relevant factors, the European Union released the 
DIRECTIVE 2010/63/EU on September 22nd, 2010 “On the protection of animals 
used for scientific purposes” that substitutes Directive 86/609/EEC. 
The new Directive focuses mainly on the animal welfare fixing the 3Rs principles as 
the foundations of the document. 
The theme of animal welfare is analysed in all its form, from the design of the 
experiment and the consequent training of the staff, to the housing of the animal and 
the control of its pain, and again from the animal breeding to the animal human 
sacrifice. 
Moreover, although the document affirm that the use of live animals in experimental 
trials continues to be necessary to protect human and animal health, the European 
Commission clearly states the responsibility of the scientific community to improve 
the number of methods that allow the replacement of live animals in experimental 
procedures. 
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Finally, “this Directive represents an important step towards achieving the final goal 
of full replacement of procedures on live animals for scientific and educational 
purposes as soon as it is scientifically possible to do so” (DIRECTIVE 2010/63/EU). 
The Italian law adopted the Directive with the “Decreto Legislativo n. 26, March 4th, 
2014”, which contains more restrictions regarding Italian scientific research. 
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The Porcine Model in Translational Research 
 
A simple PubMed research using the keywords “porcine/swine/pig animal models” 
reveals that in the last three decades there has been an exponential growth of papers 
in which the swine was considered a species of relevant interest for translational 
research and medicine (and sometimes the species of choice – Prather et al., 2013). 
Papers’ topics are the most different: the pig has been and still is used as model for 
studies in fields of embryology, physiology, pathology of human disease, nutrition, 
toxicology and agriculture. Nevertheless, the Directive 2010/63/EU also regulates the 
use of the pig, in animal-based experiments, as a not-primate animal species 
(Directive 2010/63/EU). 
 
As previously described in the present manuscript, an animal model, in order to be 
considered a valid tool for translational research, should replicate at most the human 
condition (Suzuki et al 2011). However, concerning this point, it is important to keep 
in mind that “All models – the biological ones, too  – are wrong: the practical 
question is how wrong do they have to be to not be useful ” (Box, 1987; Prather et 
al., 2013). Considering that the Directive 2010/63/EU clearly states that “the use of 
live animals in experimental trials continues to be necessary to protect human and 
animal health” (Directive 2010/63/EU), it is still important that scientists continue to 
make efforts in their researches in order to find the least worst model to represent 
human conditions without using live animals for biomedical purposes. 
 
The mouse is, nowadays, an irreplaceable model and absolutely necessary for 
advances in biomedicine. However, as human and mouse are quite different under 
many biological aspects, the generation of large animal models able to properly 
mime human diseases is needed (Fan & Lai, 2013; Prather et al., 2013). 
It is already known since many years that pig is more similar to the human species 
than other not-primate animals (Swindle et al., 2012). Moreover, it seems that the use 
of porcine models could present fewer ethical issues and societal concern than the 
use of primates and pets (i.e dogs) in biomedical trials, probably due to their use as 
livestock and food producing animals (Fan & Lai, 2013; Prather et al., 2013). 
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The biological similarities with humans are expressed at the genomic (Archibald et 
al., 2010; Bendixen et al., 2010), proteomic (de Almeida et al., 2012), anatomic and 
physiologic levels (Niemann & Kues, 2003; Suzuki et al., 2011; Swindle et al., 
2012). In addition, farm pigs and minipigs have a longer lifespan than the smaller 
laboratory animals (Fan & Lai, 2013). In particular, due to their smaller size the 
minipig strains are the appropriate choice when scientists need a more manageable 
animal/species for their research. Moreover, minipigs seem to be a better choice, 
when compared to farm pigs, because they are more mature, although with the same 
body weight, and because their tissues are more resilient to experimental procedures 
(Swindle et al., 2012; Lelovas et al., 2014). 
Nonetheless, disadvantages in the use of the pig as animal model, opposed to mouse 
and rat, lie in higher costs as well as their more complex handling, late maturity and 
long gestational period (Elmadhun et al., 2013). 
 
Looking it from a translational point of view, the porcine species has been 
recognized, indeed, as an excellent model for the study of cardiovascular diseases 
(Zaragoza et al., 2011; Elmadhun et al., 2013) and it has also led scientists to 
improve their knowledge about atherosclerosis and thrombosis pathogenesis and 
treatment (Vilahur et al., 2011; Hamamdzic & Wilensky, 2013), myocardial ischemia 
(Suzuki et al., 2011) and restenosis (Gessaroli et al., 2012; de Prado et al., 2013). 
 
Human eye pathologies, such as Leber Congenital Amaurosis and other inherited 
retinal degenerations, could also benefit from the use of pig model. Pig retina, in fact, 
displays a macular region similar to the human one, confirming in terms of 
morphology and function, its being a good model in this field of research (Fan & Lai, 
2013; Prather et al., 2013; Gün & Kues, 2014). An Italian group funded by Telethon 
grants, is currently working on these topics and developing several adeno-associated 
virus-based in vivo transgene delivery pig models in order to use the so-called gene 
therapy as a way to treat retinal diseases (Karali et al., 2011; Mussolino et al., 2011; 
Manfredi et al., 2013). 
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There is also plenty of literature in which the porcine model is employed to study 
lung diseases. Some major topics, for instance, focused on lung development and 
transplantation, ischemia-reperfusion injury, nitrous oxide and hyperoxia effect, 
pulmonary hypertension, endothelin and its receptors, asthma and other diseases 
(Rogers et al., 2008 a). 
 
Moreover, it is important to remember that a close similarity between human and 
porcine species was also described for the gastrointestinal trait (Weih et al., 2013). 
Pig has proved to be a good model in pediatric gastroenterology (Sangild et al., 
2013), especially in the research field on the short bowel syndrome (SBS) (Sangild et 
al., 2014). 
 
Furthermore, it is worth citing the enormous contribution of  genetically-modified 
pig animal models to biomedicine (Whyte & Prather, 2011); the advanced 
reproductive technologies available for this species (Sachs and Galli, 2009), the 
knowledge about its genome (Archibald et al., 2010) and the new tools the genetic 
engineering offers to scientists (Petersen et al., 2015). All these features make the pig 
model a powerful tool for the translational research (Fan & Lai, 2013). 
 
The recent advances in regenerative medicine and tissue regeneration led to the use 
of the pig animal model in this field of study too. The porcine animal model has been 
employed, especially, in cardiovascular (see i.e. Simioniuc et al., 2011) and 
orthopedic (see i.e. Sun et al., 2013) regenerative medical trials. 
 
In 2003, the NIH, taking into account all these considerations, established the 
National Swine Resource and Research Center (NSRRC) “to develop the 
infrastructure to ensure that biomedical investigators across a variety of disciplines 
have access to critically needed swine models of human health and disease” 
(http://www.nsrrc.missouri.edu). The NSRRC is probably the clearer example of the 
significance of the pig as an animal model for human diseases, given that it also 
serves as a central resource for reagents, information and training related to the use 
of swine models in biomedical research (Prather et al., 2013). 
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The following chapter presents a review of the literature concerning pig animal 
models. In particular, the following section will focus on the most important 
application of the porcine model in biomedicine, that is its relevance in 
cardiovascular diseases research field. It will also analysed useful porcine models for 
biomedical purposes obtained with genetic engineering and porcine models 
application in regenerative medicine. 
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Wild-type porcine models for cardiovascular research 
 
Cardiovascular diseases are the first causes of death (3 out of 10 deaths) all over the 
world (data related to 2000-2012 published in the WHO website 
http://www.who.int/en/). Consequently, nowadays, one of the major fields of study 
of the scientific research is the cardiovascular physio-pathology. In order to perform 
successful research, it is necessary to have a model that accurately approximates to 
the human cardiovascular morphology and function (Lelovas et al., 2014). The 
surgical community has hence recognized the swine as an excellent model replicating 
the human cardiovascular system (Prather et al., 2013). 
The features that make the swine an attractive model for cardiovascular studies can 
be found in the high similarities with humans in coronary anatomy and circulation, in 
the physiology of the heart, in hemodynamic and metabolic values, in 
pharmacokinetics and platelet function, coagulation and fibrinolysis. In addition, pigs 
tolerate invasive cardiac interventions, as well (Elmadhun et al., 2013; Fan & Lai, 
2013; Gün & Kues, 2014; Lelovas et al., 2014). 
Atherosclerosis and myocardial infarction can be experimentally induced in swines 
through diets enriched with the nutrients known for their property to elevate the risk 
for cardiovascular disorders in humans (Prather et al., 2013). Furthermore, it was 
demonstrated how some pigs develop spontaneous atherosclerotic lesions and may 
succumb to a sudden death when under stress (Vilahur et al., 2010). 
The following chapters will briefly summarized the most important wild type porcine 
models of cardiovascular diseases in order to examine them from the laboratory 
animal science point of view. 
 
Porcine models for Atherotrombotic Disease 
Atherosclerosis is a cardiovascular disease that could affect all vessels. It is 
considered an intima (the inner layer of the vessels) related disease and it is caused 
by hyperlipidemia and lipid oxidation. Fat deposits constitute the so called “intimal 
plaque” whose formation occurs due to the deposit of small cholesterol crystals in the 
intima and in the media layers of vessels. Then, the fibrous tissue and the plaque 
grow resulting into the vessels’ lumen obstruction. Clot formation and thrombosis 
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are the last stages of an atherosclerotic lesion. In particular, the possible rupture of 
the plaques could lead to thrombosis (atherothrombotic event) that is the most 
important cause of acute coronary syndrome and ischemic heart disease (Vilhaur et 
al., 2011; Zaragoza et al., 2011; Hamamdzic et al., 2013; Rafieian-Kopaei et al., 
2014). 
 
Porcine models of atherosclerotic lesion have been properly reviewed by Zaragoza 
and colleagues (2011) and by Hamamdzic and colleagues (2013). The following part 
of this work briefly describes them in order to underline the most important ones. 
 
In order to induce the atherothrombotic events in swine, it is possible to feed animals 
with an hypercholesterolemic diet that increases their cholesterol levels resembling 
the human pathological ones. Thanks to the porcine model, it is also possible to 
combine this approach with intravascular interventions (balloon angioplasty and 
stenting) in order to induce an adaptive response in pigs that resembles the human 
phenotype (Zaragoza et al., 2011). Examples of the use of the latter approach can be 
found in the Busnelli and colleagues work, were they investigated 
hypercholesterolemia from the inflammatory point of view (Busnelli et al., 2013). 
The hypercholesterolemic pig model just presented is usually coupled with the 
diabetic pig model (Hamamdzic et al., 2013) firstly described by Gerrity and 
colleagues (2001). Combining the two diets, hypercholesterolemic and 
hyperglycemic, results demonstrate that lesions closely resemble the human 
phenotype (Hamamdzic et al., 2013). 
A second porcine model of atherosclerosis is the so-called Rapacz-FH pig (Prescott 
et al., 1991). This model exhibits spontaneous atherosclerosis due to high blood 
levels of low density lipoprotein (LDL). This spontaneous phenotype is caused by a 
mutation in the LDLR gene and the consequent developments of atherosclerotic 
lesions and pathological phenotypes are highly similar to the human one (Prescott et 
al., 1991; Hamamdzic et al., 2013). Recently, the Rapacz-FH pig model has also 
been used to study the gene expression profile of valvular interstitial cells (Porras et 
al., 2014). 
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The last and noteworthy porcine model of atherosclerosis is the so-called Ossabaw 
Pig. The Ossabaw Pig develops metabolic syndrome due to a non-insulin 
spontaneous diabetes associated with an atherogenic diet. Coronary atherosclerosis 
was observed in this model by Hamamdzic and colleagues in 2013 (Hamamdzic et 
al., 2013). Recently, the Ossabaw pig has been used to investigate the cardiac 
angiogenesis in a chronical ischemic myocardium (Elmadhun et al., 2014). 
 
Porcine models for Myocardial Ischemia 
One of the main outcome of the rupture of an atherosclerotic plaque is the acute 
coronary syndrome and the consequent myocardial ischemia, due to ischemic heart 
disease (Hamamdzic et al., 2013). Coronary Artery Disease (CAD) is the first cause 
of death all over the world. This is due to two major consequences that occur in 
about the 50% of cases: acute Myocardial Infarction (MI) or sudden cardiac death 
(Iwasaki, 2014). MI is considered the main consequence of myocardial ischemia 
which, finally, leads to cell death (myocardial injury) (Whyte et al., 2014). 
The main issue to overcome, when using animals to model myocardial infarction 
pathogenesis in order to develop useful treatments, is the recreation of the so-called 
“vulnerable atherosclerotic plaque”. The pig seems to be the best species to generate 
the plaque instability (Suzuki et al., 2011; Zaragoza et al., 2011). Several porcine 
models of plaque rupture method are thoroughly detailed in the Zaragoza and 
colleagues review (Zaragoza et al., 2011). 
In addition to these previous models, induction of myocardial ischemia in pigs can be 
achieved through other approaches, among which the most commons are the surgical 
occlusion of the coronary artery and the induced supraventricular tachycardia 
(Suzuki et al., 2011; Zaragoza et al., 2011). 
Moreover, cardiac catheterization and coronary interventions are similar in pigs and 
humans. So, in order to induce heart failure and to develop procedures and treatments 
for cardiovascular diseases, the possibility to work on the pig, instead of other 
animals, with a catheter-based closed-chest technique proves notable advantages. 
(Suzuki et al., 2011). 
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Porcine models for Restenosis 
In order to treat Coronary Artery Disease (CAD), which follows the accumulation of 
atherosclerotic plaque within the lumen of carotid arteries, the most common 
procedure is the use of stents. The main problem of the coronary stent is that it 
causes restenosis (Perkins et al., 2010). 
Generally speaking, restenosis is a process that occurs in about 10-15% of patients 
treated with coronary, carotid and peripheral arteries revascularization procedures 
(Forte et al., 2014). The main pathogenic event occurring in restenosis is the 
development of the neointimal hyperplasia. It appears that neointimal hyperplasia 
could be due to the overgrowth of vascular smooth muscle cells and/or multipotent 
vascular cells migrating from the media layer of the vessels to the damaged intimal 
one (Giordano & Romano, 2011; Tang et al., 2012). An inflammatory component 
was also recognized in the development of neointimal hyperplasia (Giordano & 
Romano, 2011). 
So far, the porcine coronary model has been one of the most useful for the evaluation 
of coronary stents, as its development of the neointimal injury pathology is seen as 
the closest to the human one. Furthermore, it is important to remember that, due to 
the adult pig size, stents and all instrumentations used for humans are equally 
suitable for pigs (Vilahur et al., 2010; de Prado et al., 2013). 
Recent studies in which pigs were used as restenosis models aimed mainly to 
develop methods or devices to be employed in cardiovascular surgery. 
To this end, Cui and colleagues (2014) and Li and colleagues (2014) described the 
employment of particular stents coated with antibodies in a porcine model of 
restenosis. The aim of the studies was to develop new devices in order to overcome 
the de-endothelialization problem and prevent restenosis. 
Pérez de Prado and colleagues (2014), instead, assessed paclitaxel-eluting balloons 
efficacy in a preclinical porcine model achieving the reduction of the restenosis in 
treated animals compared to the control. 
Furthermore, Gessaroli and colleagues (2012) used the porcine model to assess a 
modified ePTFE stretch graft in order to prevent restenosis in vein-graft anastomosis. 
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Transgenic porcine models for human diseases 
 
Although the first transgenic pig was generated about thirty years ago for agricultural 
purposes, in the biomedical research field the swine is considered a species of great 
interest insomuch as, nowadays, biomedicine is the main application of genetically 
modified pigs (Sachs & Galli, 2009; Whyte & Prather, 2011; Prather et al., 2013; 
Gün & Kues, 2014). 
In particular, it is recognized that transgenic pigs are better animal models than other 
non-primate species in fields concerning neurological, cardiovascular, and diabetic 
disorders (Fan & Lai, 2013). 
Recent advances in reproductive biotechnologies applied to porcine species, genetic 
engineering techniques and molecular biology tools allowed scientists to generate 
transgenic pigs in a faster way than few years ago (Galli et al., 2010; Gün & Kues, 
2014).  
In the last 30 years, several transgenesis techniques have been developed, 
ameliorated and described (Bacci, 2007; Sachs & Galli, 2009). Among these, it is 
worth remembering the principal ones such as the pronuclear microinjection (Gordon 
et al., 1980), the Sperm Mediated Gene Transfer (Lavitrano et al., 2002), the viral-
mediated transgenesis (Whitelaw et al., 2004) and the Somatic Cell Nuclear Transfer, 
based on the animal cloning technique (Galli et al., 2010). 
The main problem with the porcine species in terms of transgenesis is the lack of 
Embryonic Stem Cell (ESC) lines which otherwise would provide a simpler way to 
generate transgenic animals (Park & Telugu, 2013). An important tool aiming to 
ameliorate the transgenesis efficiency in pigs could be the emerging induced 
Pluripotent Stem (iPS) cell  lines, already described for the porcine species (Roberts 
et al., 2009; West & Stice, 2011; Fan & Lai, 2013). 
Improvements in molecular biology knowledge and techniques led scientists to 
develop innovative technologies based on transposons, recombinases and nucleases 
(Gün & Kues, 2014). Nucleases constitute the most powerful tools emerged in the 
last few years. Among them Zinc-Finger Nucleases (ZFNs), Transcription Activator-
like Effector Nucleases (TALENs) and RNA-guided Engineered Nucleases (RGENs) 
are the most used systems (Kim & Kim, 2014; Petersen et al., 2015). Moreover, 
Porcine in vitro and ex vivo models for cardiovascular biology 
19 
 
recently, the CRISPR/Cas9 nuclease system has been employed in order to generate 
genetically modified pigs (Hai et al., 2014; Whitworth et al., 2014). 
 
In the last two decades, transgenic pigs were generated and perfected as some of 
them resulted in great animal models for human diseases. Three different reviews 
concerning transgenic pigs in biomedicine were recently edited by Fan and Lai 
(2013), Prather and colleagues (2013), and Gün and Kues (2014). The following 
sections will briefly expose the data presented in these reviews updated with the most 
recent and noteworthy scientific publications. This comprehensive revision will thus 
examine transgenic pig models for cardiovascular, nervous system and 
ophthalmological diseases, diabetes mellitus, cystic fibrosis, xenotransplantation and 
cancer.  
 
Cardiovascular Diseases 
The present manuscript has already described the similarities in terms of 
cardiovascular morphology and function between the human and the porcine species. 
In the last decade, transgenic pig models for cardiovascular diseases were generated, 
in order to allow scientists to deeply investigate the etiology and to accelerate the 
discovery of new therapies for some of these multifactorial and complex pathologies 
(Zaragoza et al., 2011; Agarwala et al., 2013; Prather et al., 2013). 
Polyunsaturated fatty acid n-3/n-6 ratio is of great importance in the cardiovascular 
field. The two models described below could help in investigating the effect on the 
cardiovascular system of an altered n-3/n-6 ratio (Prather et al., 2013). A spinach ∆12 
Fatty Acid Desaturase (FAD2) expressing transgenic pig was generated by Saeki and 
colleagues in 2004. Naturally, mammalians do not express desaturase, whose 
function is to produce the essential polyunsaturated fatty acid Linoleic Acid and α-
Linoleic Acid (Saeki et al. 2004). Moreover, a humanized Chaernobitis elegans fat1 
expressing transgenic pig was generated by Lai and colleagues; fat1 encodes a n-3 
desaturase and this lead to the alteration of polyunsaturated fatty acid n-3/n-6 in the 
transgenic pig compared to the wild-type (Lai et al., 2006). 
An important gene involved in cardiovascular biology is the endothelial Nitric Oxide 
Synthase (eNOS), an enzyme expressed by endothelial cells that generates Nitric 
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Oxide (NO). Nitric Oxide is significant as a regulator of vascular morphology and 
function (Hao et al., 2006; Whyte et al, 2010). Catalase is another enzyme expressed 
by endothelial cells that contributes to vascular tone and to the development of 
cardiovascular diseases metabolizing H2O2, another important regulator of vascular 
physiology (Whyte et al., 2011). 
Transgenic pigs expressing eNOS (Hao et al., 2006; Whyte et al, 2010) and catalase 
(Whyte et al., 2011) were generated by two different research groups. Both the 
animal models could provide important information about the contribution of NO 
and H2O2 to cardiovascular diseases and could improve the knowledge about their 
physiological function. 
Peroxisome Proliferator-Activated Receptor-γ (PPARγ) is involved in cardiovascular 
diseases and is considered a valid target for therapeutic interventions due to its role 
in fatty acid and adiponectin uptake in adipocytes. Moreover, the activation of 
PPARγ results in an increase of insulin sensitivity and glucose uptake and in an anti-
inflammatory effect (Fan & Lai, 2013; Prather et al., 2013; Gün & Kues, 2014). 
Hence, with the generation of the PPARγ-KO pig, Yang and colleagues provided to 
scientists an important tool to get new important information on the role of PPARγ in 
cardiovascular biology (Yang et al., 2011). 
An important independent risk factor for coronary heart disease is the 
hypertriglyceridemia and Apolipoprotein (Apo)CIII, which is strongly correlated 
with plasma triglyceride levels. Due to these important considerations, Wei and 
colleagues produced an ApoCIII transgenic pig model that showed important 
similarities with the human pathological phenotype and could be of great importance 
for studies on correlation of hyperlipidemia and atherosclerotic diseases (Wei et al., 
2012). 
Another interesting molecule involved in cardiovascular biology is CD39 
(ectonucleoside triphosphate diphosphohydrolase-1). Its involvement in 
cardioprotection was demonstrated in a transgenic murine model of myocardial 
ischemia/reperfusion. In 2012, Wheeler and colleagues generated a CD39 transgenic 
pig in order to investigate the translational potential of the murine model. The results 
obtained after a myocardial ischemia/reperfusion injury confirmed, as showed in the 
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murine model, that CD39 is involved in cardioprotection in the ischemic heart 
disease (Wheeler et al., 2012). 
Recently, Al-Mashhadi and colleagues generated a transgenic pig modified for the 
expression of a mutated form of the convertase subtilisin/kexin type 9 (PCSK9) gene 
that causes, in human, hypercholesterolemia and atherosclerosis. The model 
displayed the same human pathological phenotype and could provide an important 
tool to study atherosclerosis (Al-Mashhadi et al., 2013). 
 
Nervous System Diseases 
Transgenic pigs have been generated for Alzheimer’s Disease (AD), Spinal Muscolar 
Atrophy (SMA), Huntington’s Disease (HD) and Amyotrophic Lateral Sclerosis 
(ALS). 
Alzheimer’s Disease pathogenesis is not entirely known, but it seems that Amyloid 
Precursor Protein (APP) gene is a key factor in the development of this 
neurodegenerative disorder, which also leads to the loss of neurons and cognitive 
function and, at a later stage, to death. Genetically modified pigs have been 
generated through the insertion of the Swedish mutation of the human APP gene. 
Unfortunately, no symptoms related to AD and no symptomatic β peptide 
accumulation have been yet observed in the system; the potential manifestation of 
Alzheimer related symptom may take more time to develop in the present model 
(Kragh et al., 2009; Søndergaard et al., 2012). 
Spinal Muscular Atrophy is a neurodegenerative disease whose main cause is 
recognized in a mutation or a deletion of the Survival Motor Neuron (SMN)-1 gene, 
which is characterized by loss of motor neurons and skeletal muscle atrophy (Fan 
and Lai, 2013). To this end, a transgenic pig lacking just one allele of the SMN1 
gene was recently generated. Obviously, the requirement of the double KO of the 
SMN1 gene is essential in order to simulate the human phenotype of the disease 
(Lorson et al., 2011). 
Huntington’s Disease pathogenesis is related to the expansion of the CAG 
trinucleotide in the Huntingtin (HTT) gene. The disease results in a progressive loss 
of brain neurons that leads to neurological disorders related to movement, cognitive 
ability and dementia. 
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Two models of this disease were obtained by Yang and colleagues (2010) and Baxa 
and colleagues (2013). In particular, in the first the insertion of mutant HTT resulted 
in the birth of piglets with a low expression of the mutant gene, but with clear 
evidence of apoptosis in brain neurons. 
Amyotrophic Lateral Sclerosis is a fatal neurodegenerative disease and can be 
clinically distinguished into two forms: sporadic and familiar. The 20% of the 
familiar forms seems to be linked to a mutation of the Cu/Zn Superoxide Dismutase 
(SOD)-1 gene. A transgenic pig model carrying and expressing the human SOD1 
mutated gene was recently generated and characterized by Chieppa and colleagues 
(2014). 
 
Ophthalmological Disease 
Retinitis Pigmentosa are a group of inherited retinal diseases that cause loss of 
peripheral and, sometimes, central vision, mainly due to the loss of photoreceptors 
(rods for peripheral and cones for central vision) (Fan & Lai, 2013; Prather et al., 
2013; Gün & Kues, 2014). 
There were two main transgenic pig models generated for retinitis pigmentosa. The 
first one was generated by Petters and colleagues introducing a mutation in the 
Rhodopsin (RHO) gene that causes, in the pig retina, rods loss, cone photoreceptors 
degeneration and consequently the loss of their function (Petters et al., 1997). The 
second model was generated by Fernandez de Castro and colleagues, introducing a 
different mutation in the RHO gene and this resulted in a pathological phenotype 
completely similar to the human one, confirmed from the electroretinographes (Ross 
et al., 2012; Fernandez de Castro et al., 2014). 
 
Diabetes Mellitus 
Among metabolic disorders, Diabetes Mellitus is the most represented and it is 
mainly characterized by hyperglycemia. In particular, Type I, II (both insulin-
dependent) and III (insulin-independend) of Diabetes Mellitus were described and 
characterized by Wolf and colleagues (2014). 
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Recently, Renner and colleagues generated a porcine model of permanent neonatal 
diabetes introducing a mutation in the pig genome at the insulin (INS) gene level. 
The genetically modified newborn pigs showed hyperglycemia and a decreased body 
weight and β cells mass. Due to these features, this model could be of great interest 
in clinical trials (Renner et al., 2013). 
Transgenic pigs for Glucagon-like peptide (GLP)-1 were also generated. It is 
important to remember that GLP1 protein is involved in the secretion of insulin. 
These pigs showed a continuous reduction in glucose tolerance and in the number 
and mass of β cells with increasing age (Renner et al., 2010) 
Moreover, pigs were genetically modified in order to investigate the mutated 
Hepatocyte Nuclear Factor (HNF)-1α recognized as the cause of Diabetes Type III 
by Umeyama and colleagues (2009). These pigs developed diabetes due to a poor 
insulin secretion. 
 
Cystic Fibrosis 
Cystic Fibrosis (CF) is an autosomal recessive genetic disease caused, mainly, by the 
mutation in the Cystic Fibrosis Transmembrane conductance Regulator (CFTR) gene 
encoding for a ion channel protein whose function is to mediate hydration. The pig 
was proved to be a good animal model on which studying human lung diseases 
(Rogers et al., 2008 a & b). 
There are two main transgenic pig models which were developed for this pathology; 
the first was generated through the deletion of the porcine CFRT gene by Rogers and 
colleagues (2008 b) while the second was generated through the mutation of the 
CFRT gene by Ostedgaard and colleagues (2011). Both models, amazingly, resemble 
the human CF phenotype in terms of lung, liver, pancreas, bladder, bile duct, 
intestinal and vas deferens pathologies. 
However, the greatest results were achieved with the first model, which allowed 
scientists to deeply investigate CF pathogenesis. In particular, it was demonstrated 
that inflammation follows bacterial infection in CF patients lungs (Stoltz et al. 2010), 
that Insulin-like Growth Factor (IGF)-1 is correlated with CF (Rogan et al. 2010) and 
that mucociliary transport is a primary defect in CF patients lungs (Hoegger et al., 
2014). 
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Xenotransplantation 
The continuous request for organs, due to the high number of people that need 
transplants, led scientists to look for other ways to get organs donors. 
Xenotransplantation might be identified as a possible solution to the problem: getting 
organs from other species clearly allows an increase in their number in order to 
supply to this pressing request. Pig has been described as the most suitable species 
for xenotransplantation because of its size, breeding and the possibilities to modify 
its genome in terms of addition and deletion of genes (Sachs and Galli, 2009; Prather 
et al., 2013). In fact, the first of all transgenic pigs produced for biomedical purposes 
was generated for xenotransplantational studies by Cozzi and colleagues (1997). 
There are, however, two main problems related to organ xenotransplantation from 
pigs: the humoral rejection (Le Bas-Bernardet et al., 2011) and the presence of 
porcine endogenous retroviruses – PERV (Mattiuzzo et al., 2012). 
Rejection of xenotransplants from porcine to primates is basically due to the so-
called process of hyperacute rejection. Hyperacute rejection is mainly driven by pre-
existing human (and primate) antibodies able to recognize α-gal epitopes catalyzed 
by the α-1,3 galactosyl transferase (GGTA)-1 gene, which lead to rejection in a 
matter of minutes (Sachs and Galli, 2010; Prather et al., 2013; Gün & Kues, 2014). 
The production of the first Gal-KO pig in the 2003 by Phelps and colleagues (Phelps 
et al., 2003) increased the survival of the transplanted organs (2-6 months), but the 
modulation of other complement regulatory proteins (CRPs) is still necessary (Le 
Bas-Bernardet et al., 2011). Recently, other attempts to produce transgenic pigs and 
use their organs in xenotransplantational studies using the Gal-KO background were 
made and some of them showed encouraging results (Bongoni et al., 2014). 
However, it is clear that a lot of work has to be made in order to overcome the 
immunologic and zoonotic issues that xenograft presents. 
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Cancer 
The word “cancer” defines a series of more than 100 pathologies that share the 
uncontrolled cell growth as their principal feature. Different types, with different 
pathogenesis, of human cancer are known and well described (Gün & Kues, 2014). 
So far, there have been generated some porcine cancer models even if the pig has not 
yet played a critical role in experimental oncology (Flisikowska et al., 2013). 
For instance, pigs were genetically modified for the Brest Cancer Associated Gene 
(BRCA) 1 in order to provide a model for the study of the breast and ovarian cancer. 
Unfortunately, the usefulness of this model still needs to be demonstrated, as all the 
piglets died within 18 days after birth (Luo et al., 2011). 
Another transgenic pig was generated by Leuchs and colleagues in order to mime the 
Li-Fraumeni syndrome. This pig was generated with a conditionally activatable 
oncogenic mutant of the p53 oncogene that plays an important role in human cancer. 
Leuchs and colleagues observed that the model resembled very closely the human 
phenotype (Leuchs et al., 2012). 
However, the most impressive transgenic pig model generated so far is the one in 
which the Adenomatous Polyposis Coli (APC) gene was targeted. A mutation in the 
porcine APC gene (orthologous to a severe mutation in the human APC gene) closely 
resembles the Familial Adenomatous Polyposis (FAP) human phenotype. The 
founder animal revealed polyps in colon-rectum similar to human adenomas 
(Flisikowska et al., 2012). Other analysis are still in progress within the F1 
generation (Flisikowska et al., 2013). 
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Involvement of the porcine model in regenerative medicine 
 
The NIH defines regenerative medicine “a broad field that includes tissue 
engineering but also incorporates research on self-healing – where the body uses its 
own systems, sometimes with help foreign biological material to recreate cells and 
rebuild tissues and organs” (http://www.nibib.nih.gov/). 
Basically, “Regenerative medicine replaces or regenerates human cells, tissue or 
organs to restore or establish normal function” (Mason & Dunnill, 2008). 
This replacement could be achieved through several approaches among which stem 
cell transplantation, gene therapy, tissue engineering, soluble molecules delivery, cell 
reprogramming (Greenwood et al, 2006). 
Thus, it is clear that one of the milestones in regenerative medicine is definitely the 
cell and, in particular, the stem cell. Depending on their commitment, stem cells can 
be classified into totipotent, pluripotent, multipotent or progenitor/tissue specific 
cells. There are many clinical trials already approved for therapy on humans and 
many other that are currently object of studies (Mason & Dunnill, 2008; Sanchez et 
al., 2012). In particular, many encouraging results have been achieved in the field of 
cardiovascular regenerative medicine, insomuch as cell-based phase III clinical trials 
have been started (Behfar et al., 2014). Great advances have also been achieved 
within the field of bone engineering through mesenchymal stromal cell therapy 
(Grayson et al., 2015). 
 
The use of the porcine animal model was described in several biomedical works 
concerning regenerative medicine in both cardiovascular and orthopedical fields. 
 
Porcine animal model and cardiovascular regeneration 
Regenerative medicine is a promising way to overcome cardiovascular diseases even 
though the many issues it still presents nowadays (cell graft composition, cell 
selection, cell differentiation) and that need to be overcome (Dai & Foley, 2014). 
 
The pig has been used as a model for cardiovascular regeneration in order to 
overtake some of these issues. 
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A pig model of balloon induced-myocardial infarction was used by Grøgaard and 
colleagues in order to evaluate how the injected cell homed to the infarcted tissue. 
Autologous progenitor cells were intravenous or intracoronary injected. Results 
showed a greater number of infused cells in infarcted myocardium after 
intracoronary than intravenous injection (Grøgaard et al., 2007). 
Instead, data obtained by Halkos and colleagues, who again used a pig model of 
myocardial infarction, suggest that intravenous injection of MSCs stimulate 
reperfusion of the ischemic myocardium resulting in the improvement of the cardiac 
function (Halkos et al., 2008). Similar results were also achieved by Krause and 
colleagues who obtained, with a similar method, a reduction of the infarct size and, 
again, an improvement of the cardiac function (Krause et al., 2007). Moreover, data 
obtained from Sato and colleagues suggested a neovascularization process induced 
by the autologous MSCs intracoronary injection in the porcine infarcted heart (Sato 
et al., 2011). 
Simionuc and colleagues also tested the effect of the injection of placental derived-
MSCs pre-treated with a hyaluronan mixed ester of butyric and retinoic acid on 
infarcted porcine hearts. Infarct size were reduced as well as fibrous tissue, and 
vascularization was enhanced after the injection of pre-treated cells compared to the 
injection of untreated cells (Simioniuc et al., 2011). 
In order to assess whether delivery efficiency based on the site of injection was 
different, van der Spoleen and colleagues injected intracoronary or trans-
endocardium bone marrow MSCs in a porcine model of myocardial infarction. No 
differences were observed by the authors in the delivery efficiency between these 
two approaches (van der Spoleen et al., 2012). 
Using a transgenic line of human induced Pluripotent Stem Cells (hiPSCs), modified 
for the expression of the sodium iodide symporter (NIS), Templin and colleagues 
demonstrated, for the first time in a porcine model of myocardial infarction, that 
hiPSCs are able to differentiate to endothelial cells contributing to the 
neovascularization of the infarcted heart (Templin et al., 2012). 
Furthermore, by using the same model Wright and colleagues demonstrated that the 
delivery of alginate encapsulated MSCs, modified for the expression of a Glucagon-
like peptide (GLP)-1, after myocardial infarction, improves left ventricular function, 
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reduces the infarct size and increases the number of vessels, probably due to a 
paracrine supply of GLP-1 and other stem cell factors (Wright et al., 2012). 
In addition, recent studies on the porcine model allowed to assess the use of three-
dimensional systems for stem cell therapy of the infarcted heart (Emmert et al., 
2013). 
 
Porcine animal model and bone regeneration 
By employing animal model adult bone marrow- and adipose tissue-derived 
mesenchymal stromal cells (MSCs) were used in clinical trials for bone regeneration 
(Grayson et al., 2015). 
 
The porcine model was used in order to assess bone regeneration in mandibular 
distraction. It was shown that autologous bone marrow MSCs delivery in a Gelfoam 
scaffold to the distraction site improves the osteogenic process in pig mandible (Sun 
et al., 2013). The pig model was also previously used to demonstrated that stem cells 
isolated from deciduous teeth are able to engraft and repair a critical lesion at the 
mandibular level (Zheng et al., 2009). 
The porcine model helped studying cartilage defect repair, as well. In their recent 
study, Wang and colleagues modified bone marrow MSCs for the expression of Bone 
Morphogenetic Protein (BMP)-2 and Transforming Growth Factor (TGF)β3 through 
an adenoviral vector. Cells were cultured with demineralized bone matrix (DBN) and 
the resulting engineered scaffolds were used for surgery in pigs on which a knee 
defect had been surgically generated. Results obtained demonstrate that the DBN 
engineered with MSCs modified for the expression of BMP2 and TGFβ3 elicit the 
cartilage repair in vivo. Authors state that this could be a possible clinical treatment 
for cartilage damage (Wang et al., 2014). 
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Relevant porcine models developed at the BCM laboratory 
 
The BCM laboratory (Biotecnologie Cellulari e Molecolari) was founded at the 
University of Bologna by Professors Forni and Bacci about 20 years ago. The present 
work was written while attending this facility. Since its foundation, the BCM 
laboratory has been dealing with in vivo, ex vivo and in vitro porcine models, 
developed for translational purposes. 
Initially, transgenic pig models through SMGT were generated within the field of 
xenotransplantation (Lavitrano et al., 1999; Lavitrano et al., 2002; Webster et al., 
2005; Manzini et al., 2006; Smolenski et al., 2007; Vargiolu et al., 2010). 
Moreover, in vivo and in vitro porcine models were used, by the research group, to 
investigate the physiology of reproduction (Bacci et al., 1996; Bernardini et al., 
2003; Forni et al., 2003; Bernardini et al., 2004; Zannoni et al., 2006; Ribeiro et al., 
2007 a, Ribeiro et al., 2007 b; Zannoni et al., 2007). 
Recently, it was also studied some aspects of the porcine gastrointestinal physiology 
(Dall’aglio et al., 2011; Dall’aglio et al., 2013) and pig was used as a model to study 
the chronic ingestion of toxin contaminated food (Bernardini et al., 2014). 
In vivo and ex vivo porcine models were developed, in the cardiovascular field, in 
order to study the effects of carbon monoxide (CO) in an ischemia/reperfusion injury 
model (Lavitrano et al., 2004) and in an endotoxic shock model (Mazzola et al., 
2005; Forni et al., 2005; Zannoni et al., 2010; Zannoni et al., 2012). In the field of 
cardiovascular diseases, an in vivo model of mild hypercholesterolemia was 
developed in order to study vascular injury (Busnelli et al., 2009; Busnelli et al., 
2013).  
In vitro cultures of porcine Aortic Endothelial Cells (pAEC) were developed by the 
research group, to study the vascular response to different shock (Bernardini et al., 
2005; Bernardini et al. 2010; Bernardini et al., 2012). 
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AIM OF THE STUDY 
Porcine in vitro and ex vivo models for cardiovascular biology 
31 
 
The main purpose of the previous chapter was to thoroughly describe the pig animal 
model in the most of its features and applications in translational research. 
In particular, it has been underlined the great similarity between the porcine and the 
human species within the field of cardiovascular physio-pathology. Moreover, it has 
been discussed the main reasons why the pig is considered an excellent model for 
translational medicine by the scientific community. 
As clearly stated in the European DIRECTIVE 2010/63/EU on the protection of 
animals used for scientific purposes “it is desirable to replace the use of live animals 
in procedures by other methods not entailing the use of live animals, the use of live 
animals continues to be necessary to protect human and animal health and the 
environment (DIRECTIVE 2010/63/EU – [10])”. At the same time, the directive 
states that: “The availability of alternative methods is highly dependent on the 
progress of the research into the development of alternatives. The Community 
Framework Programmes for Research and Technological Development provided 
increasing funding for projects which aim to replace, reduce and refine the use of 
animals in procedures (DIRECTIVE 2010/63/EU – [46])”. 
It is clear from these statements that the request of the European Union to the 
scientific community is to develop and characterize new alternative methods to 
animal experimentation. 
Considering these requests and the twenty year experience of the BCM laboratory in 
managing pig animal models, the main purpose of this PhD thesis was to develop and 
characterize novel porcine alternative methods for cardiovascular translational 
biology/medicine. 
The work has been based mainly on two different models: the first consists in an ex 
vivo culture of porcine aortic cylinders and the second consists in an in vitro culture 
of porcine aortic derived progenitor cells. 
 
The development and the characterization of the ex vivo aortic cylinders method 
(organ culture) was carried out with the aim to provide a new tool for the study of 
cardiovascular physio-pathology, in particular for the study of vascular restenosis. 
Specific culture conditions were set up in order to resemble the physiological context 
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(vessel wall) and to overcome some limitations of the standard in vitro culture of 
endothelial and vascular smooth muscle cells. 
 
The isolation and characterization of progenitor cells from porcine aorta was 
performed with the aim to provide a new in vitro system to study cardiovascular 
biology, from both physiological and pathological points of view, considering the 
importance of the pig in the regenerative medicine field. The aim of that work was to 
establish a newer and simpler method for isolating and culturing mesenchymal 
stromal-like cells from the porcine aorta. In order to employ this new method in the 
field cardiovascular translational research, a fine characterization of the 
differentiation potential of these cells was considered of particular importance. 
 
The following two chapters will describe the two methods, respectively. 
In particular, the aortic organ culture method has already been published in ATLA – 
Alternatives To Laboratory Animals Journal and in 2013 it was selected as the best 
article published in the journal (“Dorothy Hegarty Award 2013”). 
The isolation and culture method for mesenchymal stromal-like cells from porcine 
aorta has been published in American Journal of Physiology (AJP) – Cell 
Physiology, while their full differentiation potential characterization has been 
described in another article submitted to the same journal. 
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DEVELOPMENT OF  
A VESSEL ORGAN CULTURE SYSTEM 
TO STUDYCARDIOVASCULAR BIOLOGY
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Brief overview on the research 
 
As stated in the aim chapter, the description on the developed vessel organ culture 
system and the characterization of it was published in ATLA, in 2013 (Zaniboni et al., 
2013). The following pages will report the entire article in order to give the reader an 
exact description of the method and of the characterization results. 
 
The method was based on the idea to develop a model that could resemble, in vitro, 
the cardiovascular physio-pathological condition that occurs in vivo. This system was 
developed in particular for studies within the field of vascular restenosis.  
 
As already explained an in vitro system cannot fully resemble the enormous 
complexity of a whole organism. 
 
Within the cardiovascular research field, endothelial cells are considered the 
principal players in physiological and pathological conditions. Therefore, our attempt 
with this vessel organ culture system was to overcome the most important limitation 
of the primary endothelial cell culture, that is the lack of the physiological context: 
the vessel wall. 
 
Clearly, our endeavor to propose a new vessel organ culture system is not the first 
one. 
Vessel organ culture methods have been already described in the past (Gotlieb & 
Boden, 1984; Koo & Gotlieb, 1991; Merrick et al., 1997; Lyubimov & Gotlieb, 
2004; Gelati et al., 2008; Bellacen & Lewis, 2009), although no one considered the 
fact that the vessel wall is made up of different cell types with obvious different 
metabolical and nutritional requests. The novelty of our methods consists exactly in 
this: we cultured cylinders of pig aorta using two different culture media, liquid for 
the inner layer and semi-solid for the outer layer. 
 
The characterization of the system stability was based on molecular biology and 
histological techniques in order to analyze the production of molecules related to the 
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endothelial cell biology and to identify possible pathological cells (i.e. 
myofibroblasts involved in restenosis [Shy et al., 1997]). 
 
It was then possible to demonstrate the stability of the organ culture system, thus 
offering the scientific community a new tool to study the cardiovascular physio-
pathology, as well as new possible treatments for vascular diseases. 
 
Lastly, in 2014, the scientific contribution of our work to the 3Rs of Russell and 
Burch was awarded with the “Dorothy Hegarty Award 2013” by the editorial board 
of ATLA. The Award is presented annually to the authors of the paper published the 
previous year in ATLA which is likely to make the most significant contribution to 
the reduction, refinement and/or replacement of animal experimentation. 
 
In conclusion, with the present work we reached our goal. We set up a new method 
for the study of vascular biology also abiding by the request of the EU Directive 
2010/63/EU to develop and characterize new in vitro – ex vivo models. 
 
Article 
 
Zaniboni A, Zannoni A, Bernardini C, De Cecco M, Bombardi C, Seren E, Forni M, 
Bacci ML. Development of a vessel organ culture system: characterisation of the 
method and implications for the reduction of animal experiments. Altern Lab 
Anim 2013;41(4):259-69. (PMID: 24168133) 
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I would like to thank the FRAME Publications Director Susan Trigwell for the 
permission to insert the whole paper into this manuscript 
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DEVELOPMENT OF 
A PRIMARY CULTURE OF 
MESENCHYMAL-LIKE STROMAL CELLS 
DERIVED FROM PORCINE AORTA 
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Mesenchymal Stromal Cells (MSCs): a brief history 
 
Mesenchymal Stem Cells (MSCs) were described for the first time by Friedstein and 
colleagues as bone marrow derived progenitor cells. In their papers the authors 
described a subpopulation of bone marrow – nonhemopoietic clonogenic cells able to 
rapidly adhere to plastic with a fibroblast-like morphology (CFU-Fs – colony 
forming unit-fibroblasts). These cells owned an in vivo osteogenic potential showed 
through cell transplantation experiments (Friedenstein et al., 1968, 1970, 1974; 
Owen & Friedenstien, 1988; Keating, 2012). Their osteogenic potential in vivo 
corresponds to the possibility to generate, in an heterotopic location, a new-formed 
ossicle in which all skeletal tissues (bone, cartilage, adipose tissue and fibrous tissue) 
can be recognized (Uccelli et al., 2008; Bianco et al., 2008; Bianco et al., 2013; 
Frenette et al., 2013). These cells were further defined osteogenic stem cells 
(Friedenstein et al., 1987). Osteogenic stem cells were shown to be able to 
differentiate towards the adipo-, chondro- and osteocytic lineages not only in vivo, 
but also in vitro (Pittenger et al., 1999). 
 
Based on the evidence of in vivo multipotency and on the suggestion of self-renewal 
of the bone marrow derived stem cells, Caplan (1991) coined the term 
“Mesenchymal Stem Cells” (Caplan, 1991).  
 
In the 1990s and 2000s a plethora of papers concerning the isolation of the so-called 
“Mesenchymal Stem Cells” from different tissues (not only from the bone marrow) 
and with different methods have been published. As such, a significant debate 
concerning the requirement of new terminologies and different criteria to better 
define these cells started to grow among scientific community (Keating et al., 2012). 
 
In order to better clarify and define these points, the International Society for 
Cellular Therapy published (ISCT) two position papers. (Horwitz et al., 2005; 
Dominici et al., 2006). 
First of all, the authors invite the reader to refer to the most of these cells as 
multipotent “Mesenchymal Stromal Cells – MSCs” (due to their tissues of origin). 
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The term “Mesenchymal Stem Cells”, they argue, is only to use when the stem cell 
properties are clearly demonstrated (Horwitz et al., 2005; Dominici et al., 2006). 
On this subject Bianco and colleagues stated that, in order to define MSCs as “stem”, 
a precise assessment of the self-renewal and of the multilineage potential is needed 
(Bianco et al., 2008). 
However, the overlap between the acronyms used for both the mesenchymal stromal 
and stem cells (MSCs) may result confusing. Thus, from now on in the paper the 
acronym MSCs will be used only to refer to multipotent Mesenchymal Stromal Cells. 
 
The ISCT also defined some fundamentals criteria in order to define MSCs: 1) these 
cells have to adhere to plastic in standard culture conditions, 2) they have to express 
CD105 (endoglin), CD90 (Thy-1 - Thymocyte differentiation antigen 1), CD73 
(ecto-5'-nucleotidase) surface markers and lack the expression of the hemopoietic 
markers 3) they have to differentiate in vitro towards the adipo-, osteo- and 
chondrocytic phenotypes (Horwitz et al., 2005; Dominici et al., 2006). 
 
Many studies have already described that, nowadays, it exists the possibility to 
isolate MSCs populations from adipose tissue, placenta, umbilical cord blood, 
Wharton’s Jelly, dental pulp, amniotic fluid, synovial membranes and other tissues 
(Singer & Caplan, 2011; Keating et al., 2012; Murray et al., 2014). 
 
In bone marrow the function of Mesenchymal Stem Cells is to support hemopoiesis 
and to stabilize and to help the development of sinusoidal network (Sacchetti et al., 
2007; Kunisaki et al., 2013; Frenette et al., 2013). 
Sacchetti and colleagues (2007) demonstrated for the first time that CD146 (MCAM 
–Melanoma Cell Adhesion Molecule) positive clones of Mesenchymal Stem Cells, 
derived from bone marrow stroma, are able to re-generate an hemopoietic 
microenviroment if transplanted in vivo into an heterotopic site (Bianco et al., 2008; 
Bianco et al., 2013; Frenette et al., 2013). The function of the bone marrow 
Mesenchymal Stem Cells in the hemopoietic niche was also properly reviewed by 
Frenette and colleagues (2013). 
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Figure 1: Paracrine mechanisms of action of MSCs. MSCs secrete a broad range of bioactive 
molecules and growth factors which are essential in immunomodulation, apoptosis, angiogenesis, 
maintenance of hemopoietic niche, antiscarring processes and chemoattraction. The 
immunomodulary effect is achieved through the inhibition of both innate and adaptive immune 
mechanisms secreting molecules able to inhibit proliferation of CD4+ and CD8+ lymphocytes and 
natural killer cells, to suppress the production of immunoglobulin as well as to inhibit the maturation 
of dendritic cells and to stimulate the proliferation of regulatory T cells. Anti-apoptotic mechanism is 
guided by growth factors such as: Hepatocyte Growth Factor (HGF), Transforming Growth Factor 
(TGF)-β, Vascular Endothelial Growth Factor (VEGF), Insulin-like Growth Factor (IGF)-1 and 
Granulocyte Macrophage-Colony Stimulating Factor (GM-CSF). VEGF and IGF-1 are involved in 
the pro-angiogenic effect of MSCs with other extracellular matrix (ECM) molecules, basic Fibroblast 
Growth Factor (bFGF) and interleukin (IL)-6. Moreover, HGF and bFGF contribute to the inhibition 
of scarring. MSCs stimulate mitosis of hemopoietic progenitors secreting Stem Cell Factor (SCF), 
Macrophage Colony–Stimulating Factor (M-CSF), Stromal cell–derived Factor (SDF-1), Leukemia 
Inhibiting Factor (LIF) and angiopoietin 1. Finally, the chemoattraction of leukocyte to a site of 
injury is also driven by MSCs through the secretion of chemokines (Singer & Caplan, 2011). 
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Regenerative medicine is likely to be the major field of therapeutic application of 
MSCs (Frenette et al., 2013). Within regenerative medicine, the clinical interest of 
MSCs resides in their documented paracrine properties. 
 
It is thought, that through soluble factors release, MSCs are able to carry out their 
therapeutic functions. Trophic and immunomodulatory molecules released by MSCs 
are involved in immunomodulation, apoptosis, angiogenesis, hemopoietic niche 
maintenance, fibrosis and chemoattraction (da Silva Meirelles et al., 2009; Singer 
and Caplan, 2011) as shown in Figure 1. 
 
MSCs secretome came into focus in several research fields, among which the 
development of cell therapy for cardiovascular diseases (i.e. for ischemic heart 
disease). A better and more exact characterization of secreted cytokines and trophic 
factors would help in understanding the therapeutic effects of these cells (Ranganath 
et al., 2012). 
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Perivascular Cells and Vascular Stem Cells (VSCs) 
 
The demonstration that Mesenchymal Stem Cells in the bone marrow sinusoids are 
perivascular cells (Sacchetti et al., 2007; Bianco et al., 2013) led scientists to look for 
the niche of those MSCs derived from the other tissues of the organism. MSCs are, in 
fact, the most elusive population of adult multipotent cells (Murray et al., 2014). 
 
According to the copious number of papers stating that MSCs may be isolated from 
almost all vascularized organs, some authors define perivascular cells (aka mural 
cells) as the possible source of the ubiquitous MSCs in vivo (Murray et al., 2014). 
Conversely, other authors claim that these mural cells are just tissue specific 
progenitors, with specific differentiation potential, and that further studies are needed 
in order to clearly define their features (Bianco et al., 2013). 
 
Despite the ongoing scientific debates regarding nomenclature, source, in vivo 
location and differentiation potential of mesenchymal stem/stromal/progenitor cells, 
it’s now been several years since the presence of progenitor cells within the vessel 
wall was described for the first time (Tintut et al., 2003; Pacilli & Pasquinelli, 2009; 
Psaltis et al., 2011; Chen et al., 2012; Murray et al., 2014). 
 
A lot of work has indeed been done in order to characterize and describe these 
populations of perivascular cells, although it has been reported that a prospective 
approach might help in isolating them (Chen et al., 2012; Corselli et al., 2013 b; 
Murray et al., 2014). 
 
In particular, three main cell types were isolated through prospective purification: 
myoendothelial cells (MECs) (Zheng et al., 2007), pericytes (PCs) (Crisan et al., 
2008) and advential cells (ACs) (Corselli et al., 2012). 
 
Prospective isolation is based on an initial in vivo characterization of the cells. This 
procedure is performed through immunodetection in order to find the few surface 
markers whose combination univocally identifies the cell type of interest. Then, 
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using a Fluorescence Activated Cell Sorting (FACS) approach, it is possible to 
isolate pure populations of mural cells for the co-expression of those surface markers 
and the lack of the unspecific ones. 
Basically, tissues are digested by a collagenase treatment and then monocellular 
suspension is stained with anti- CD146 (MCAM), CD34, CD56 (NCAM – Neural 
Cell Adhesion Molecule), CD45 (PTPRC – Protein Tyrosine Phosphatase, Receptor 
type, C), CD31 (PECAM – Platelet Endothelial Cell Adhesion Molecule) or CD144 
(Vascular Endothelial (VE)-Cadherin) antibodies. The perivascular cells from intima, 
media and adventitia layers of the vessel wall are then sorted according to the marker 
combinations shown in Figure 2 (Chen et al., 2012; Corselli et al., 2013 b; Murray et 
al., 2014). Figure 2 describes differentiation potential, both in vivo and in vitro, of 
perivascular cells and their potential preclinical application (Chen et al., 2012). 
 
 
 
Figure 2: In the present table myoendothalial cells (MEC), pericytes and adventitial cells (AC) 
immunophenotype, differentiation potential, both in vivo and in vitro, and potential clinical 
application was reported by Chen and colleagues (2012) (Chen et al., 2012). 
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The potential of pericytes in regenerative medicine found its targets in the treatment 
of myocardial ischemia (Chen et al., 2013; Chen et al., 2015), peripheral ischemia 
(Dar et al., 2012) and bone regeneration (James et al., 2012). 
Moreover, recent data demonstrated that CD146 positive perivascular cells support 
hemopoietic stem/progenitor cells via cell-cell interactions (Corselli et al., 2013 a). 
 
Perivascular cells, as described by Chen and colleagues (2012), are not the only 
population of cells identified within the vessel wall. In their work, Psaltis and 
colleagues (2011) review in detail the bibliography related to mural and perivascular 
cells describing mesangioblasts, vascular smooth muscle precursors and progenitors, 
endothelial progenitors and pericytes, as well as their involvement in physio-
pathological processes (Psaltis et al., 2011; Chen et al., 2012). 
 
A recent review by Lin and Lue (2013) properly describes a series of vascular wall 
resident multipotent cells among which the so-called Vascular Stem Cells (VSCs). 
The authors state that VSCs indeed correspond to MSCs due to their trilineage 
differentiation potential and due also to their ability to differentiate towards the 
vascular smooth muscle and endothelial phenotypes. Pericytes and adventitial cells 
are recognized, by the authors, as the most plausible VSCs population within the 
vessel wall (Lin & Lue, 2013). 
 
Perivascular cells, as well as vascular resident multipotent cells, can also be involved 
in vascular pathology (Hu & Xu, 2011). In particular, Tang and colleagues (2012) 
demonstrated that multipotent vascular stem cells are involved in neointimal 
hyperplasia in restenosis (Tang et al., 2012). 
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Porcine multipotent mesenchymal stromal cells 
 
Porcine MSCs (pMSCs) have already been isolated and described (Casado et al., 
2012). Nonetheless, due to the lack of anti-pig specific antibodies and of cross-
reactivity with some anti-human antibodies, their proper phenotypical 
characterization is quite difficult (Rozemuller et al., 2010). However, the isolation 
and characterization of pMSCs have been carried out anyway in order to develop 
translational models for regenerative medicine/cell transplantation purposes. 
 
Comite and colleagues (2010) described the isolation of pMSCs from bone marrow. 
Cells were isolated depending on their adhesion properties to plastic support and 
characterized for the expression of CD105, CD90 and CD29 (Integrin beta-1) and the 
lack of the expression of CD45 and CD11b (Integrin alpha M) (Comite et al., 2010). 
Moreover, bone marrow derived pMSCs displayed an osteogenic and adipogenic 
potential in vitro. 
Peterbauer-Scherb and colleagues (2010) induced chondrogenic differentiation of 
bone marrow derived pMCSs with the aim to utilize these cells in porcine models of 
regenerative medicine within the orthopedic field (Peterbauer-Scherb et al., 2010). 
 
A comparison between bone marrow derived human MSCs (hMSCs) and pMSCs 
was carried out by Noort and colleagues (2012). From the phenotypical point of 
view, these species share the expression of the surface markers CD90, CD44 
(Homing Cell Adhesion Molecule – HCAM), CD29, CD271 (Nerve Growth Factor 
Receptor – NGFR), CD146, CD56 and the lack of the expression of CD34, CD45, 
CD14 and HLA (Human Leukocyte Antigen)/SLA (Swine Leukocyte Antigen) class 
II. Trilineage differentiation potential was demonstrated for both hMSCs and 
pMSCs. Injection of hMSCs and pMSC in murine model of myocardial ischemia 
resulted in improvement of ejection fraction compared to PBS injection. These data 
confirmed the usefulness of the pig model in cell therapy-based regenerative 
medicine (Noort et al., 2012). 
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Recently, Brückner and colleagues (2014) demonstrated the hepatocytic 
differentiation of bone marrow and adipose derived pMSCs. Differentiated cells were 
morphologically and functionally characterized in order to validate the pig model to 
study liver physio-pathology, as well (Brückner et al., 2014). 
 
All these data confirm the importance and the relevance of the pig in cell based 
regenerative medicine, as widely described in the previous chapter “Involvement of 
the porcine model in regenerative medicine”. 
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Isolation of MSC-like cells from porcine aorta: purposes and papers 
 
As stated in the aim chapter, two papers were produced with the data obtained from 
this research. 
The first paper was published in the American Journal of Cell Physiology (AJP) – 
cell physiology (Zaniboni et al., 2014) and pertains the establishment of a new 
method for the isolation of MSC-like cells derived from porcine aorta media layer. 
The cells were properly described and characterized in the first paper. The same were 
then cultured in a perivascular cells specific medium. Thus, the differentiation 
potential of these cells towards the cell phenotypes constituting the vascular wall was 
assessed in order to evaluate their VSCs properties. These results were then drafted 
in another article that is currently submitted for publication in AJP – cell physiology. 
 
Considering the importance of the vascular wall resident MSCs in fields of 
regenerative medicine (Chen et al., 2102; Lin & Lue, 2013), the main purpose of 
these works was to develop a new, well characterized and useful in vitro tool to study 
the vascular biology and the pathogenesis of cardiovascular diseases (Hu & Xu, 
2011; Tang et al., 2012). 
 
The in vitro system developed in this research led to a reduction and a refinement of 
animal experimentation because aortas could be recovered from animals killed at 
slaughterhouse or from control animal sacrificed for other experimental purposes. 
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Development of the method and characterization of cells 
 
The isolation of the cells was carried out by modifying a method previously 
published by the BCM laboratory (Bernardini et al., 2005), routinely used for the 
isolation of porcine Aortic Endothelial Cells (pAECs). 
The new method is based on the collagenase digestion of the porcine aorta from the 
inner side of the vessel. After forty minutes of digestion of the vessel wall, cellular 
suspension is recovered (endothelial cell fraction) and the aorta is filled with 
collagenase solution, again. After other four hours of digestion, cellular suspension is 
newly recovered, then seeded in a cell culture flask and cultured overnight in an high 
antibiotic-antimycotic medium. After three days of culture in a standard culture 
medium (DMEM with 10% Fetal Bovine Serum – FBS) cells are serum starved and 
then routinely cultured and expanded. 
 
For the purposes of the work, Passage 3 (P3) cells were characterized for surface 
marker expression, trilineage differentiation potential and for their pericyte-like 
properties in supporting angiogenesis. 
 
Results obtained from the histological analysis of the vessel wall revealed that, after 
forty minutes of collagenase digestion, the intima layer is completely lost and, after 
four hours, about one third of the media layer is digested. These results suggested a 
media layer in vivo localization of the isolated cells. 
 
The phenotypical characterization revealed that cells derived from porcine aorta 
media layer expressed, in vitro, several MSC-pericyte markers. 
In particular, immunocytochemical analysis revealed the expression of vimentin, 
laminin, nestin, Platelet Derived Growth Factor Receptor (PDGFR)-α, PDGFR-β, 
Neural Glial antigen-2 (NG2) and α-Smooth Muscle Actin as described for cultured 
pericytes (Howson et al., 2005; Crisan et al., 2008). No expressions of smooth 
muscle (smooth muscle myosin-heavy chain) and endothelial cell (PECAM aka 
CD31) markers were detected. 
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Immunophenotyping of cells revealed, instead, the expression of CD105, CD90, 
CD44 and the lack of expression of CD45 and CD34 as requested for MSCs 
(Dominici et al., 2006). Moreover, as already described for sub-population of MSCs 
by several authors, (Battula et al., 2009; Bühring et al., 2009; Rossignoli et al., 2013) 
the expression of CD56 were shown for cells derived from porcine aorta media layer. 
Besides these phenotypical data, gene expression analysis through PCR revealed the 
presence of CD105, CD90, CD73 transcripts. 
 
Trilineage differentiation potential was also shown for cells derived from porcine 
aorta media layer that differentiated towards the adipo-, osteo- and chondrocytic 
phenotypes, as requested for MSCs (Dominici et al., 2006). 
 
Lastly, through an in vitro angiogenesis assay, based on the co-culture with Human 
Umbilical Vein Endothelial Cells (HUVEC) seeded on extracellular matrix, it was 
demonstrated the support of the cells derived from porcine aorta media layer to the 
angiogenic process. This is considered a particular feature of pericytes (Blocki et al., 
2013). 
 
Taking into account all the results obtained from the analysis of the cells derived 
from porcine aorta media layer it is possible to conclude that: 
- the method hereby described is simple and suitable as it allows to isolate a 
predominant population of cells from porcine aorta media layer; 
- these cells share phenotypical and differentiative features with MSCs; 
- these cells share phenotypical and functional features with pericytes. 
All these considerations led to define these cells as porcine Aortic Precursor Cells 
(pAVPCs) due to their MSC/pericyte-like nature. 
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Article 
 
Unfortunately, the full-text article cannot be published in the electronic version of 
this thesis due to AJP copyright policy.  
However, the reader can find the paper using the following reference: 
 
Zaniboni A, Bernardini C, Alessandri M, Mangano C, Zannoni A, Bianchi F, Sarli G, 
Calzà L, Bacci ML, Forni M. Cells derived from porcine aorta tunica media show 
mesenchymal stromal-like cell properties in in vitro culture. Am J Physiol Cell 
Physiol 2014;306(4):C322-33. (PMID: 24304832) 
 
Abstract 
(see the screenshot from PubMed website below) 
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Differentiation potential through the vascular smooth muscle and the 
endothelial phenotypes 
 
As previously described, porcine Aortic Precursor Cells have been properly 
characterized as MSC/pericyte-like cells for surface markers expression, trilineage 
differentiation potential and their support to angiogenesis in vitro (Zaniboni et al., 
2014). 
 
Cells were cultured in a standard culture medium constituted of Dulbecco's Modified 
Eagle Medium (DMEM) and Medium 199 (M199) (ratio 1:1) added with 10% of 
Fetal Bovine Serum (FBS) with 1% of antibiotic – antimycotic (DM medium). 
Despite the characterization results, it has been observed that cells cultured in DM 
medium undergo towards the loss of multipotency and towards the so-called “cellular 
senescence” due to several passages in vitro (observation). 
 
In order to overcome the limits of the in vitro culture with the DM medium, the 
protocol herby described was modified with the purpose of culturing pAVPCs in a 
pericytes specific medium (Pericytes Growth Medium, Promocell – PGM). 
 
MSC/pericyte properties of pAVPCs cultured in PGM were then assessed and, 
moreover, the differentiation towards the vascular smooth muscle and the endothelial 
cell phenotypes was evaluated, too. 
 
The change of culture conditions involved an equivalent one in cell morphology. 
Cells cultured in DM medium displayed a fibroblast-like morphology (as described 
for MSCs – Dominici et al., 2006), while cells cultured in PGM displayed a small 
cell body with little thin arms (as described for pericytes – Crisan et al., 2008). 
Moreover, cells cultured in PGM grew more rapidly than cells cultured in DM 
medium; doubling time is reduced of about 10 hours among DM culture and PGM 
culture (Zaniboni et al., 2014). 
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Passage 3 pAVPCs were characterized for the expression of MSC/perivascular cell 
transcripts through quantitative Polymerase Chain Reaction (qPCR). The expression 
of CD105, CD90, CD73, CD56 and the lack of CD45 transcripts were shown for 
PGM cultured pAVPC, as for MSCs (Dominici et al,. 2006, Rossignoli et al., 2013). 
Nonetheless, PGM cultured cells expressed transcripts of NG2, Nestin, CD146, 
αSMA, PDGFRβ, which are considered the main pericytes markers (Crisan et al., 
2008), and CD34 transcript, which is considered a marker of adventitial cells and 
myoendothelial cells (Corselli et al., 2012). Both transcripts of the growth factor 
VEGF and PDGFβ were also detected as well as the expression of VEGF receptor 
(VEGFR)-1 and VEGFR-2. 
 
Moreover, the work also investigated phenotypical features of PGM cultured cells. 
Passage 3 pAVPC expressed CD105 (66.8 ± 0.1 %), CD90 (99.5 ± 0.2 %), CD44 
(99.6 ± 0.3 %) and lacked (less than 2%) the expression of CD45 (1.4 ± 0.4 %), 
CD34 (1.3 ± 0.1 %), as requested for MSCs characterization (Dominici et al., 2006). 
To exclude possible endothelial cells contaminations, cells were analyzed for the 
expression of CD31 and just 1.5 ± 0.1 % of them expressed it. Moreover, cells 
expressed CD56 (99.9 ± 0.1 %) an MSC-subset marker (Battula et al., 2009; Bühring 
et al., 2009; Rossignoli et al., 2013). 
Immunocytochemistry revealed the expression of PDGFRβ, NG2 and Nestin pericyte 
markers and the lack of expression of αSMA (less than 2%). The latter is considered 
a differentiation marker for multipotent pericytes. It is present in fully differentiated 
functional pericytes, instead it lacks in the multipotent ones. Conversely to the results 
obtained for the DM culture, the lack of expression of αSMA indicates that PGM is 
able to maintain cells in an uncommitted status (Crisan et al., 2012). Cells do not 
express CD34 and CD31 proteins. 
Results obtained from the PGM cultured pAVPC phenotypical analysis revealed a 
more uniform population of MSC/pericytes-like cells, compared to the culture in DM 
(Zaniboni et al., 2014). 
 
Mesenchymal Stromal Cells in vitro trilineage differentiation potential (Dominci et 
al., 2006) was also evaluated for PGM cultured pAVPCs. After adipo-, osteo-, 
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chondrogenic differentiation induction, qPCR results showed the expression of 
typical markers of fully differentiated adipocytes, osteocytes and chondrocytes, 
respectively. Moreover, histological analysis revealed lipid droplets, within the cells 
bodies, in adipo-differentiated cells, calcium deposits in osteo-differentiated cells and 
proteoglicans in chondro-differentiated cells. 
 
To assess the spontaneous differentiation towards the vascular smooth muscle 
phenotype (Tang et al., 2012), pAVPCs were cultured for 21 days in DMEM + 10% 
FBS (long term medium – LTM). Quantitative PCR analysis revealed an 
overexpression of αSMA, calponin (CNN1) and smooth muscle myosin heavy chain 
(SMM-hc) transcripts (Xie et al., 2011). Immunocytochemistry revealed the 
expression of αSMA and SMM in LTM cultured cells compared to control. These 
data confirmed that pAVPCs are able to spontaneously differentiate to vascular 
smooth muscle cells as already described by Tang and colleagues (2012) for other 
multipotent vascular cells. 
 
To assess the differentiation potential of PGM cultured cells towards the endothelial 
cell phenotype, cells were cultured for 21 days in an endothelial cell medium (EDM 
medium), supplemented with VEGF. Quantitative PCR analysis revealed an 
overexpression of CD31, vascular endothelial(VE)-Cadherin, von Willebrand Factor, 
endothelial nitric oxide synthase (eNOS) transcripts (Xie et al., 2011). Moreover, 
immunocytochemistry revealed the expression of CD31 in EDM cultured cells 
compared to control. These data confirmed that pAVPCs are able to differentiate 
towards the endothelial cell phenotype, as already described for porcine bone 
marrow-derived MSCs by Pankajakshan and colleagues (2013). 
 
Taken together, these results confirmed that cells cultured in PGM possess 
MSC/pericyte properties (Dominici et al. 2006) and that they display VSC-like 
features according to the definition given by Lin and Lue (2013) of Vascular Stem 
Cells (Lin & Lue, 2013). 
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In particular, culturing pAVPCs in PGM allowed the isolation of a uniform 
population of mesenchymal cells which possessed trilineage differentiation potential, 
vascular smooth muscle and endothelial differentiation potential. Nonetheless, it is 
worth to remember that the pro-angiogenic properties of pAVPCs cultured in PGM 
had already been demonstrated (Zaniboni et al., 2014) through an in vitro 
angiogenesis assay with HUVEC. 
The method hereby described offers important starting points to the purposes of 
regenerative medicine considering the peculiarity of these cells to differentiate 
towards the endothelial lineage (Dar et al., 2012; James et al., 2012; Chen et al., 
2013). It is also equally important to underline the spontaneous ability of the same 
cells to differentiate towards the vascular smooth muscle cell phenotype and so, their 
possible involvement in vascular diseases pathogenesis, as already described for 
other vascular derived multipotent cell types (Juchem et al., 2010; Hu & Xu, 2011; 
Tang et al., 2012). 
 
In conclusion, according to the recent Lin & Lue review, it is possible to define 
porcine Aortic Vascular Precursor Cells as a population of Vascular Stem Cell-like 
cells. 
Indeed, when considering the importance of the porcine model within the 
cardiovascular research field, further investigation are required in order to define 
these cells possible involvement in vascular pathology and regenerative medicine. 
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Submission to AJP-Cell Physiology 
 
 
Confirmation email: please note that the web URL to access the paper page has been modified in 
order to avoid any inconvenience with the online publication of the thesis. 
 
As said above, the paper describing the vascular smooth muscle and the endothelial 
differentiation of pAVPCs is currently submitted for review to the AJP-Cell 
Physiology (see confirmation email above). 
Although it is not possible to insert the whole work into the present thesis, due to 
publication policy, the previous pages describe in detail its full content and its most 
important remarks. 
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CONCLUDING REMARKS 
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The present manuscript reports an attempt to expand the range of already existing ex 
vivo and in vivo methods to study cardiovascular biology. 
With the Directive 2010/63/EU, the European Union, asked the scientific community 
to establish, characterize and validate new alternative methods to animal 
experimentation for translational research. 
 
The choice of the porcine species as the subject of the research is based on the 
continuous evidence that the pig is the most similar non-primate animal model to the 
human species. Moreover, the pig has been shown to be a valuable animal model 
within the cardiovascular research field both for physiology and pathology. 
There are several wild-type and transgenic porcine models generated for biomedicine 
and translational research fields of study. Among these, the cardiovascular ones are 
indeed the most represented. 
 
This work was then based on the development of two models which take into 
account Russell and Burch’s 3Rs (Reduction, Refinement, Replacement). In 
particular, both the models led to a Refinement and to a Reduction of animal 
experimentation. 
 
The first method consists in an organ culture of porcine aorta developed with the aim 
to supply the scientific community with a new tool in vascular biology research field. 
Due to the fact that the model consists in the culture of portions of the aorta it 
resembles the in vivo physiological condition more than primary cell culture of 
endothelial cells does. 
The results obtained from the histological and molecular characterization of the 
method proved not only that it closely mimes the in vivo conditions, but also that it is 
a stable system, at least for fourteen days of culture. The most immediate application 
of the aorta organ culture is its use in the study of vascular restenosis and more 
widely in the study of vascular physio-pathology. 
 
The second method consists in a primary in vitro culture of precursor cells derived 
from porcine aorta, developed with the aim to provide a new tool within the fields of 
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cell-based translational medicine and vascular pathology. This new tool was thought 
up in order to supply the scientific community with a simpler and more suitable 
method allowing the isolation of a large number of Mesenchymal Stromal/Vascular 
Stem Cell-like cells. 
Precursor cells, isolated from the pig aorta, were characterized for surface markers 
expression, differentiation potential and support to angiogenesis in vitro. 
The results obtained confirmed that these cells possess Vascular Stem Cell-like 
properties, due to the fact that they express MSC markers, display trilineage 
differentiation potential, differentiate towards vascular smooth muscle and 
endothelial cell phenotypes, and support angiogenesis in vitro. 
 
In conclusion, the continuous involvement of the porcine animal model in the 
biomedical research, as the continuous advances achieved using this species in 
translational medicine, support the need for alternative methods to animal 
experimentation involving pigs. 
 
Both the models described in the present manuscript were properly characterized and 
could be useful to the study of vascular biology. Moreover, both the models aim to 
reduce the use of experimental animals and to refine animal based-trials. 
 
Because of the European Legislation and the Laboratory Animal Science guidelines 
there is no question of the relevance of further research concerning alternative 
methods to animal experimentation within the next future. 
The present research aims to be a small, but significant, contribution to this important 
and necessary field of study. 
  
PhD thesis – Andrea Zaniboni, 2015 
70 
 
ACKNOWLEDGMENTS 
Porcine in vitro and ex vivo models for cardiovascular biology 
71 
 
The realization of the present manuscript was possible thanks to the guide and the 
collaboration of several people who I would like to thank in this chapter. 
 
First of all, it is right and proper to thank my supervisor, Prof. Monica Forni, who 
hosted me for four years in her BCM lab and who greatly guided me all over my PhD 
formation and research activities. 
Professor Maria Laura Bacci, as well, has proved to be of great importance not only 
in my formation as a researcher but also in the development of all the work here 
described. 
I would also like to thank Dr. Augusta Zannoni and Dr. Chiara Bernardini, who 
generously contributed to the improvement of my scientific and technical knowledge 
and whose work was of extreme importance for the development of the methods here 
described. 
Moreover, I would like to acknowledge the scientific and technical contribution of 
Dr. Martina Bertocchi for the research concerning the development of the in vitro 
culture of precursor cells from porcine aorta. 
 
The scientific and technical collaboration with the researchers of the University of 
Bologna was essential for the fulfillment of these works, and I would like to thank all 
of them. 
 
In particular, the organ culture method was developed in close collaboration with 
Prof. Cristiano Bombardi, while the establishment of the in vitro culture of porcine 
aortic precursor cells was developed in collaboration with Prof. Laura Calzà, Prof. 
Giuseppe Sarli, Dr. Chiara Mangano, Dr. Marco Alessandri, Dr. Giancarlo Avallone 
and Dr. Francesca Bianchi. 
 
Last but not least, I would like to thank Prof. Bruno Péault for hosting me in his 
laboratory at the University of Edinburgh where, working with Dr. James Baily, I 
was able to improve my knowledge of perivascular cell biology. This has been an 
essential opportunity not only for my personal knowledge and academic progress, 
but also for the realization of the work concerning precursor cells from pig aorta. 
PhD thesis – Andrea Zaniboni, 2015 
72 
 
 
REFERENCES 
Porcine in vitro and ex vivo models for cardiovascular biology 
73 
 
Basel Declaration - A call for more trust, transparency and communication on animal 
research. November 29, 2010. 
 
DIRECTIVE 2010/63/EU - on the protection of animals used for scientific purposes. 
September 22nd, 2010. 
 
Agarwala A, Billheimer J, Rader DJ. Mighty minipig in fight against cardiovascular 
disease. Sci Transl Med 2013;5(166):166. 
 
Al-Mashhadi RH, Sørensen CB, Kragh PM, Christoffersen C, Mortensen MB, 
Tolbod LP, Thim T, Du Y, Li J, Liu Y and others. Familial hypercholesterolemia and 
atherosclerosis in cloned minipigs created by DNA transposition of a human PCSK9 
gain-of-function mutant. Sci Transl Med 2013;5(166):166. 
 
Archibald AL, Bolund L, Churcher C, Fredholm M, Groenen MA, Harlizius B, Lee 
KT, Milan D, Rogers J, Rothschild MF and others. Pig genome sequence--analysis 
and publication strategy. BMC Genomics 2010;11:438. 
 
Bacci ML, Barazzoni AM, Forni M, Costerbosa GL. In situ detection of apoptosis in 
regressing corpus luteum of pregnant sow: evidence of an early presence of DNA 
fragmentation. Domest Anim Endocrinol 1996;13(4):361-72. 
 
Bacci ML. A brief overview of transgenic farm animals. Vet Res Commun 2007;31 
Suppl 1:9-14. 
 
Battula VL, Treml S, Bareiss PM, Gieseke F, Roelofs H, de Zwart P, Müller I, 
Schewe B, Skutella T, Fibbe WE and others. Isolation of functionally distinct 
mesenchymal stem cell subsets using antibodies against CD56, CD271, and 
mesenchymal stem cell antigen-1. Haematologica 2009;94(2):173-84. 
 
PhD thesis – Andrea Zaniboni, 2015 
74 
 
Baxa M, Hruska-Plochan M, Juhas S, Vodicka P, Pavlok A, Juhasova J, Miyanohara 
A, Nejime T, Klima J, Macakova M and others. A transgenic minipig model of 
Huntington's Disease. J Huntingtons Dis 2013;2(1):47-68. 
 
Behfar A, Crespo-Diaz R, Terzic A, Gersh BJ. Cell therapy for cardiac repair--
lessons from clinical trials. Nat Rev Cardiol 2014;11(4):232-46. 
 
Bellacen K, Lewis EC. Aortic ring assay. J Vis Exp 2009(33). 
 
Bendixen E, Danielsen M, Larsen K, Bendixen C. Advances in porcine genomics 
and proteomics--a toolbox for developing the pig as a model organism for molecular 
biomedical research. Brief Funct Genomics 2010;9(3):208-19. 
 
Bernardini C, Fantinati P, Castellani G, Forni M, Zannoni A, Seren E, Bacci ML. 
Alteration of constitutive heat shock protein 70 (HSC70) production by in vitro 
culture of porcine preimplanted embryos. Vet Res Commun 2003;27 Suppl 1:575-8. 
 
Bernardini C, Fantinati P, Zannoni A, Forni M, Tamanini C, Bacci ML. Expression 
of HSP70/HSC70 in swine blastocysts: effects of oxidative and thermal stress. Mol 
Reprod Dev 2004;69(3):303-7. 
 
Bernardini C, Zannoni A, Turba ME, Fantinati P, Tamanini C, Bacci ML, Forni M. 
Heat shock protein 70, heat shock protein 32, and vascular endothelial growth factor 
production and their effects on lipopolysaccharide-induced apoptosis in porcine 
aortic endothelial cells. Cell Stress Chaperones 2005;10(4):340-8. 
 
Bernardini C, Zannoni A, Bacci ML, Forni M. Protective effect of carbon monoxide 
pre-conditioning on LPS-induced endothelial cell stress. Cell Stress Chaperones 
2010;15(2):219-24. 
 
Porcine in vitro and ex vivo models for cardiovascular biology 
75 
 
Bernardini C, Greco F, Zannoni A, Bacci ML, Seren E, Forni M. Differential 
expression of nitric oxide synthases in porcine aortic endothelial cells during LPS-
induced apoptosis. J Inflamm (Lond) 2012;9(1):47. 
 
Bernardini C, Grilli E, Duvigneau JC, Zannoni A, Tugnoli B, Gentilini F, Bertuzzi T, 
Spinozzi S, Camborata C, Bacci ML and others. Cellular stress marker alteration and 
inflammatory response in pigs fed with an ochratoxin contaminated diet. Res Vet Sci 
2014;97(2):244-50. 
 
Bianco P, Robey PG, Simmons PJ. Mesenchymal stem cells: revisiting history, 
concepts, and assays. Cell Stem Cell 2008;2(4):313-9. 
 
Bianco P, Cao X, Frenette PS, Mao JJ, Robey PG, Simmons PJ, Wang CY. The 
meaning, the sense and the significance: translating the science of mesenchymal stem 
cells into medicine. Nat Med 2013;19(1):35-42. 
 
Blocki A, Wang Y, Koch M, Peh P, Beyer S, Law P, Hui J, Raghunath M. Not All 
MSCs Can Act as Pericytes: Functional In Vitro Assays to Distinguish Pericytes 
from Other Mesenchymal Stem Cells in Angiogenesis. Stem Cells Dev 
2013;22(17):2347-55. 
 
Bongoni AK, Kiermeir D, Jenni H, Bähr A, Ayares D, Klymiuk N, Wolf E, Voegelin 
E, Constantinescu MA, Seebach JD and others. Complement dependent early 
immunological responses during ex vivo xenoperfusion of hCD46/HLA-E double 
transgenic pig forelimbs with human blood. Xenotransplantation 2014;21(3):230-43. 
 
Box GEP, Draper NR. Empirical Model Building. New York: John Wiley & Sons; 
1987. 
 
Brückner S, Tautenhahn HM, Winkler S, Stock P, Dollinger M, Christ B. A fat 
option for the pig: hepatocytic differentiated mesenchymal stem cells for 
translational research. Exp Cell Res 2014;321(2):267-75. 
PhD thesis – Andrea Zaniboni, 2015 
76 
 
 
Bühring HJ, Treml S, Cerabona F, de Zwart P, Kanz L, Sobiesiak M. Phenotypic 
characterization of distinct human bone marrow-derived MSC subsets. Ann N Y 
Acad Sci 2009;1176:124-34. 
 
Busnelli M, Froio A, Bacci ML, Giunti M, Cerrito MG, Giovannoni R, Forni M, 
Gentilini F, Scagliarini A, Deleo G and others. Pathogenetic role of 
hypercholesterolemia in a novel preclinical model of vascular injury in pigs. 
Atherosclerosis 2009;207(2):384-90. 
 
Busnelli M, Manzini S, Froio A, Vargiolu A, Cerrito MG, Smolenski RT, Giunti M, 
Cinti A, Zannoni A, Leone BE and others. Diet induced mild hypercholesterolemia 
in pigs: local and systemic inflammation, effects on vascular injury - rescue by high-
dose statin treatment. PLoS One 2013;8(11):e80588. 
 
Caplan AI. Mesenchymal stem cells. J Orthop Res 1991;9(5):641-50. 
 
Casado JG, Gomez-Mauricio G, Alvarez V, Mijares J, Tarazona R, Bernad A, 
Sanchez-Margallo FM. Comparative phenotypic and molecular characterization of 
porcine mesenchymal stem cells from different sources for translational studies in a 
large animal model. Vet Immunol Immunopathol 2012;147(1-2):104-12. 
 
Chen CW, Corselli M, Péault B, Huard J. Human blood-vessel-derived stem cells for 
tissue repair and regeneration. J Biomed Biotechnol 2012;2012:597439. 
 
Chen CW, Okada M, Proto JD, Gao X, Sekiya N, Beckman SA, Corselli M, Crisan 
M, Saparov A, Tobita K and others. Human pericytes for ischemic heart repair. Stem 
Cells 2013;31(2):305-16. 
 
Chen WC, Baily JE, Corselli M, Díaz ME, Sun B, Xiang G, Gray GA, Huard J, 
Péault B. Human myocardial pericytes: multipotent mesodermal precursors 
exhibiting cardiac specificity. Stem Cells 2015;33(2):557-73. 
Porcine in vitro and ex vivo models for cardiovascular biology 
77 
 
 
Chieppa MN, Perota A, Corona C, Grindatto A, Lagutina I, Vallino Costassa E, 
Lazzari G, Colleoni S, Duchi R, Lucchini F and others. Modeling amyotrophic 
lateral sclerosis in hSOD1 transgenic swine. Neurodegener Dis 2014;13(4):246-54. 
 
Comite P, Cobianchi L, Avanzini MA, Zonta S, Mantelli M, Achille V, De Martino 
M, Cansolino L, Ferrari C, Alessiani M and others. Isolation and ex vivo expansion 
of bone marrow-derived porcine mesenchymal stromal cells: potential for application 
in an experimental model of solid organ transplantation in large animals. Transplant 
Proc 2010;42(4):1341-3. 
 
Corselli M, Chen CW, Sun B, Yap S, Rubin JP, Péault B. The tunica adventitia of 
human arteries and veins as a source of mesenchymal stem cells. Stem Cells Dev 
2012;21(8):1299-308. 
 
Corselli M, Chin CJ, Parekh C, Sahaghian A, Wang W, Ge S, Evseenko D, Wang X, 
Montelatici E, Lazzari L and others. Perivascular support of human hematopoietic 
stem/progenitor cells. Blood 2013 a;121(15):2891-901. 
 
Corselli M, Crisan M, Murray IR, West CC, Scholes J, Codrea F, Khan N, Péault B. 
Identification of perivascular mesenchymal stromal/stem cells by flow cytometry. 
Cytometry A 2013 b;83(8):714-20. 
 
Cozzi E, Tucker AW, Langford GA, Pino-Chavez G, Wright L, O'Connell MJ, 
Young VJ, Lancaster R, McLaughlin M, Hunt K and others. Characterization of pigs 
transgenic for human decay-accelerating factor. Transplantation 1997;64(10):1383-
92. 
 
Crisan M, Yap S, Casteilla L, Chen CW, Corselli M, Park TS, Andriolo G, Sun B, 
Zheng B, Zhang L and others. A perivascular origin for mesenchymal stem cells in 
multiple human organs. Cell Stem Cell 2008;3(3):301-13. 
 
PhD thesis – Andrea Zaniboni, 2015 
78 
 
Cui S, Liu JH, Song XT, Ma GL, Du BJ, Lv SZ, Meng LJ, Gao QS, Li K. A novel 
stent coated with antibodies to endoglin inhibits neointimal formation of porcine 
coronary arteries. Biomed Res Int 2014;2014:428619. 
 
da Silva Meirelles L, Fontes AM, Covas DT, Caplan AI. Mechanisms involved in the 
therapeutic properties of mesenchymal stem cells. Cytokine Growth Factor Rev 
2009;20(5-6):419-27. 
 
Dai Y, Foley A. Tissue engineering approaches to heart repair. Crit Rev Biomed Eng 
2014;42(3-4):213-27. 
 
Dall'aglio C, Zannoni A, Forni M, Bacci ML, Ceccarelli P, Boiti C. Orexin system 
expression in the gastrointestinal tract of pigs. Res Vet Sci 2013;95(1):8-14. 
 
Dall'Aglio C, Zannoni A, Mercati F, Forni M, Bacci ML, Boiti C. Differential gene 
expression and immune localization of the orexin system in the major salivary glands 
of pigs. Regul Pept 2011;172(1-3):51-7. 
 
Dar A, Domev H, Ben-Yosef O, Tzukerman M, Zeevi-Levin N, Novak A, 
Germanguz I, Amit M, Itskovitz-Eldor J. Multipotent vasculogenic pericytes from 
human pluripotent stem cells promote recovery of murine ischemic limb. Circulation 
2012;125(1):87-99. 
 
de Almeida AM, Bendixen E. Pig proteomics: a review of a species in the crossroad 
between biomedical and food sciences. J Proteomics 2012;75(14):4296-314. 
 
de Prado AP, Perez-Martinez C, Cuellas C, Gonzalo-Orden JM, Diego A, Regueiro 
M, Martinez-Fernandez B, Altonaga JR, Marin Francisco JG, Fernandez-Vazquez F. 
Preclinical evaluation of coronary stents: focus on safety issues. Curr Vasc 
Pharmacol 2013;11(1):74-99. 
 
Porcine in vitro and ex vivo models for cardiovascular biology 
79 
 
Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans 
R, Keating A, Prockop D, Horwitz E. Minimal criteria for defining multipotent 
mesenchymal stromal cells. The International Society for Cellular Therapy position 
statement. Cytotherapy 2006;8(4):315-7. 
 
Dothel G, Vasina V, Barbara G, De Ponti F. Animal models of chemically induced 
intestinal inflammation: predictivity and ethical issues. Pharmacol Ther 
2013;139(1):71-86. 
 
Elmadhun NY, Sabe AA, Robich MP, Chu LM, Lassaletta AD, Sellke FW. The pig 
as a valuable model for testing the effect of resveratrol to prevent cardiovascular 
disease. Ann N Y Acad Sci 2013;1290:130-5. 
 
Elmadhun NY, Sabe AA, Lassaletta AD, Chu LM, Kondra K, Sturek M, Sellke FW. 
Metabolic syndrome impairs notch signaling and promotes apoptosis in chronically 
ischemic myocardium. J Thorac Cardiovasc Surg 2014;148(3):1048-55; discussion 
1055. 
 
Emmert MY, Wolint P, Winklhofer S, Stolzmann P, Cesarovic N, Fleischmann T, 
Nguyen TD, Frauenfelder T, Böni R, Scherman J and others. Transcatheter based 
electromechanical mapping guided intramyocardial transplantation and in vivo 
tracking of human stem cell based three dimensional microtissues in the porcine 
heart. Biomaterials 2013;34(10):2428-41. 
 
Fan N, Lai L. Genetically modified pig models for human diseases. J Genet 
Genomics 2013;40(2):67-73. 
 
Fernandez de Castro JP, Scott PA, Fransen JW, Demas J, DeMarco PJ, Kaplan HJ, 
McCall MA. Cone photoreceptors develop normally in the absence of functional rod 
photoreceptors in a transgenic swine model of retinitis pigmentosa. Invest 
Ophthalmol Vis Sci 2014;55(4):2460-8. 
 
PhD thesis – Andrea Zaniboni, 2015 
80 
 
Flisikowska T, Merkl C, Landmann M, Eser S, Rezaei N, Cui X, Kurome M, 
Zakhartchenko V, Kessler B, Wieland H and others. A porcine model of familial 
adenomatous polyposis. Gastroenterology 2012;143(5):1173-5.e1-7. 
 
Flisikowska T, Kind A, Schnieke A. The new pig on the block: modelling cancer in 
pigs. Transgenic Res 2013;22(4):673-80. 
 
Forni M, Zannoni A, Tamanini C, Bacci ML. Opposite regulation of clusterin and 
LH receptor in the swine corpus luteum during luteolysis. Reprod Nutr Dev 
2003;43(6):517-25. 
 
Forni M, Mazzola S, Ribeiro LA, Pirrone F, Zannoni A, Bernardini C, Bacci ML, 
Albertini M. Expression of endothelin-1 system in a pig model of endotoxic shock. 
Regul Pept 2005;131(1-3):89-96. 
 
Forni M. Laboratory animal science: a resource to improve the quality of science. 
Vet Res Commun 2007;31 Suppl 1:43-7. 
 
Forte A, Rinaldi B, Berrino L, Rossi F, Galderisi U, Cipollaro M. Novel potential 
targets for prevention of arterial restenosis: insights from the pre-clinical research. 
Clin Sci (Lond) 2014;127(11):615-34. 
 
Frenette PS, Pinho S, Lucas D, Scheiermann C. Mesenchymal stem cell: keystone of 
the hematopoietic stem cell niche and a stepping-stone for regenerative medicine. 
Annu Rev Immunol 2013;31:285-316. 
 
Friedenstein AJ, Petrakova KV, Kurolesova AI, Frolova GP. Heterotopic of bone 
marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. 
Transplantation 1968;6(2):230-47. 
 
Porcine in vitro and ex vivo models for cardiovascular biology 
81 
 
Friedenstein AJ, Chailakhjan RK, Lalykina KS. The development of fibroblast 
colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell 
Tissue Kinet 1970;3(4):393-403. 
 
Friedenstein AJ, Chailakhyan RK, Latsinik NV, Panasyuk AF, Keiliss-Borok IV. 
Stromal cells responsible for transferring the microenvironment of the hemopoietic 
tissues. Cloning in vitro and retransplantation in vivo. Transplantation 
1974;17(4):331-40. 
 
Friedenstein AJ, Chailakhyan RK, Gerasimov UV. Bone marrow osteogenic stem 
cells: in vitro cultivation and transplantation in diffusion chambers. Cell Tissue Kinet 
1987;20(3):263-72. 
 
Galli C, Perota A, Brunetti D, Lagutina I, Lazzari G, Lucchini F. Genetic engineering 
including superseding microinjection: new ways to make GM pigs. 
Xenotransplantation 2010;17(6):397-410. 
 
Gelati M, Aplin AC, Fogel E, Smith KD, Nicosia RF. The angiogenic response of the 
aorta to injury and inflammatory cytokines requires macrophages. J Immunol 
2008;181(8):5711-9. 
 
Gerrity RG, Natarajan R, Nadler JL, Kimsey T. Diabetes-induced accelerated 
atherosclerosis in swine. Diabetes 2001;50(7):1654-65. 
 
Gessaroli M, Bombardi C, Giunti M, Bacci ML. Prevention of neointimal 
hyperplasia associated with modified stretch expanded polytetrafluoroethylene 
hemodialysis grafts (Gore) in an experimental preclinical study in swine. J Vasc Surg 
2012;55(1):192-202. 
 
Giordano A, Romano A. Inhibition of human in-stent restenosis: a molecular view. 
Curr Opin Pharmacol 2011;11(4):372-7. 
 
PhD thesis – Andrea Zaniboni, 2015 
82 
 
Gordon JW, Scangos GA, Plotkin DJ, Barbosa JA, Ruddle FH. Genetic 
transformation of mouse embryos by microinjection of purified DNA. Proc Natl 
Acad Sci U S A 1980;77(12):7380-4. 
 
Gotlieb AI, Boden P. Porcine aortic organ culture: a model to study the cellular 
response to vascular injury. In Vitro 1984;20(7):535-42. 
 
Grayson WL, Bunnell BA, Martin E, Frazier T, Hung BP, Gimble JM. Stromal cells 
and stem cells in clinical bone regeneration. Nat Rev Endocrinol 2015. 
 
Greenwood HL, Singer PA, Downey GP, Martin DK, Thorsteinsdóttir H, Daar AS. 
Regenerative medicine and the developing world. PLoS Med 2006;3(9):e381. 
 
Grøgaard HK, Sigurjonsson OE, Brekke M, Kløw NE, Landsverk KS, Lyberg T, 
Eriksen M, Egeland T, Ilebekk A. Cardiac accumulation of bone marrow 
mononuclear progenitor cells after intracoronary or intravenous injection in pigs 
subjected to acute myocardial infarction with subsequent reperfusion. Cardiovasc 
Revasc Med 2007;8(1):21-7. 
 
Gün G, Kues WA. Current progress of genetically engineered pig models for 
biomedical research. Biores Open Access 2014;3(6):255-64. 
 
Hai T, Teng F, Guo R, Li W, Zhou Q. One-step generation of knockout pigs by 
zygote injection of CRISPR/Cas system. Cell Res 2014;24(3):372-5. 
 
Halkos ME, Zhao ZQ, Kerendi F, Wang NP, Jiang R, Schmarkey LS, Martin BJ, 
Quyyumi AA, Few WL, Kin H and others. Intravenous infusion of mesenchymal 
stem cells enhances regional perfusion and improves ventricular function in a porcine 
model of myocardial infarction. Basic Res Cardiol 2008;103(6):525-36. 
 
Porcine in vitro and ex vivo models for cardiovascular biology 
83 
 
Hamamdzic D, Wilensky RL. Porcine models of accelerated coronary 
atherosclerosis: role of diabetes mellitus and hypercholesterolemia. J Diabetes Res 
2013;2013:761415. 
 
Hao YH, Yong HY, Murphy CN, Wax D, Samuel M, Rieke A, Lai L, Liu Z, 
Durtschi DC, Welbern VR and others. Production of endothelial nitric oxide synthase 
(eNOS) over-expressing piglets. Transgenic Res 2006;15(6):739-50. 
 
Hoegger MJ, Fischer AJ, McMenimen JD, Ostedgaard LS, Tucker AJ, Awadalla 
MA, Moninger TO, Michalski AS, Hoffman EA, Zabner J and others. Cystic 
fibrosis. Impaired mucus detachment disrupts mucociliary transport in a piglet model 
of cystic fibrosis. Science 2014;345(6198):818-22. 
 
Hooijmans CR, Ritskes-Hoitinga M. Progress in using systematic reviews of animal 
studies to improve translational research. PLoS Med 2013;10(7):e1001482. 
 
Horwitz EM, Le Blanc K, Dominici M, Mueller I, Slaper-Cortenbach I, Marini FC, 
Deans RJ, Krause DS, Keating A, Therapy ISfC. Clarification of the nomenclature 
for MSC: The International Society for Cellular Therapy position statement. 
Cytotherapy 2005;7(5):393-5. 
 
Howson KM, Aplin AC, Gelati M, Alessandri G, Parati EA, Nicosia RF. The 
postnatal rat aorta contains pericyte progenitor cells that form spheroidal colonies in 
suspension culture. Am J Physiol Cell Physiol 2005;289(6):C1396-407. 
 
Hu Y, Xu Q. Adventitial biology: differentiation and function. Arterioscler Thromb 
Vasc Biol 2011;31(7):1523-9. 
 
Iwasaki K. Myocardial ischemia is a key factor in the management of stable coronary 
artery disease. World J Cardiol 2014;6(4):130-9. 
 
PhD thesis – Andrea Zaniboni, 2015 
84 
 
James AW, Zara JN, Corselli M, Askarinam A, Zhou AM, Hourfar A, Nguyen A, 
Megerdichian S, Asatrian G, Pang S and others. An abundant perivascular source of 
stem cells for bone tissue engineering. Stem Cells Transl Med 2012;1(9):673-84. 
 
Juchem G, Weiss DR, Gansera B, Kemkes BM, Mueller-Hoecker J, Nees S. 
Pericytes in the macrovascular intima: possible physiological and pathogenetic 
impact. Am J Physiol Heart Circ Physiol 2010;298(3):H754-70. 
 
Karali M, Manfredi A, Puppo A, Marrocco E, Gargiulo A, Allocca M, Corte MD, 
Rossi S, Giunti M, Bacci ML and others. MicroRNA-restricted transgene expression 
in the retina. PLoS One 2011;6(7):e22166. 
 
Keating A. Mesenchymal stromal cells: new directions. Cell Stem Cell 
2012;10(6):709-16. 
 
Keramaris NC, Kanakaris NK, Tzioupis C, Kontakis G, Giannoudis PV. 
Translational research: from benchside to bedside. Injury 2008;39(6):643-50. 
 
Kilkenny C, Parsons N, Kadyszewski E, Festing MF, Cuthill IC, Fry D, Hutton J, 
Altman DG. Survey of the quality of experimental design, statistical analysis and 
reporting of research using animals. PLoS One 2009;4(11):e7824. 
 
Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving bioscience 
research reporting: The ARRIVE guidelines for reporting animal research. J 
Pharmacol Pharmacother 2010;1(2):94-9. 
 
Kilkenny C, Browne WJ, Cuthi I, Emerson M, Altman DG. Improving bioscience 
research reporting: the ARRIVE guidelines for reporting animal research. Vet Clin 
Pathol 2012;41(1):27-31. 
 
Kim H, Kim JS. A guide to genome engineering with programmable nucleases. Nat 
Porcine in vitro and ex vivo models for cardiovascular biology 
85 
 
 
Koo EW, Gotlieb AI. Neointimal formation in the porcine aortic organ culture. I. 
Cellular dynamics over 1 month. Lab Invest 1991;64(6):743-53. 
 
Kragh PM, Nielsen AL, Li J, Du Y, Lin L, Schmidt M, Bøgh IB, Holm IE, Jakobsen 
JE, Johansen MG and others. Hemizygous minipigs produced by random gene 
insertion and handmade cloning express the Alzheimer's disease-causing dominant 
mutation APPsw. Transgenic Res 2009;18(4):545-58. 
 
Krause U, Harter C, Seckinger A, Wolf D, Reinhard A, Bea F, Dengler T, Hardt S, 
Ho A, Katus HA and others. Intravenous delivery of autologous mesenchymal stem 
cells limits infarct size and improves left ventricular function in the infarcted porcine 
heart. Stem Cells Dev 2007;16(1):31-7. 
 
Kunisaki Y, Bruns I, Scheiermann C, Ahmed J, Pinho S, Zhang D, Mizoguchi T, 
Wei Q, Lucas D, Ito K and others. Arteriolar niches maintain haematopoietic stem 
cell quiescence. Nature 2013;502(7473):637-43. 
 
Lai L, Kang JX, Li R, Wang J, Witt WT, Yong HY, Hao Y, Wax DM, Murphy CN, 
Rieke A and others. Generation of cloned transgenic pigs rich in omega-3 fatty acids. 
Nat Biotechnol 2006;24(4):435-6. 
 
Lavitrano M, Stoppacciaro A, Bacci ML, Forni M, Fioretti D, Pucci L, Di Stefano C, 
Lazzereschi D, Rughetti A, Ceretta S and others. Human decay accelerating factor 
transgenic pigs for xenotransplantation obtained by sperm-mediated gene transfer. 
Transplant Proc 1999;31(1-2):972-4. 
 
Lavitrano M, Bacci ML, Forni M, Lazzereschi D, Di Stefano C, Fioretti D, Giancotti 
P, Marfé G, Pucci L, Renzi L and others. Efficient production by sperm-mediated 
gene transfer of human decay accelerating factor (hDAF) transgenic pigs for 
xenotransplantation. Proc Natl Acad Sci U S A 2002;99(22):14230-5. 
 
PhD thesis – Andrea Zaniboni, 2015 
86 
 
Lavitrano M, Smolenski RT, Musumeci A, Maccherini M, Slominska E, Di Florio E, 
Bracco A, Mancini A, Stassi G, Patti M and others. Carbon monoxide improves 
cardiac energetics and safeguards the heart during reperfusion after cardiopulmonary 
bypass in pigs. FASEB J 2004;18(10):1093-5. 
 
Le Bas-Bernardet S, Tillou X, Poirier N, Dilek N, Chatelais M, Devallière J, 
Charreau B, Minault D, Hervouet J, Renaudin K and others. Xenotransplantation of 
galactosyl-transferase knockout, CD55, CD59, CD39, and fucosyl-transferase 
transgenic pig kidneys into baboons. Transplant Proc 2011;43(9):3426-30. 
 
Lelovas PP, Kostomitsopoulos NG, Xanthos TT. A comparative anatomic and 
physiologic overview of the porcine heart. J Am Assoc Lab Anim Sci 
2014;53(5):432-8. 
 
Leuchs S, Saalfrank A, Merkl C, Flisikowska T, Edlinger M, Durkovic M, Rezaei N, 
Kurome M, Zakhartchenko V, Kessler B and others. Inactivation and inducible 
oncogenic mutation of p53 in gene targeted pigs. PLoS One 2012;7(10):e43323. 
 
Li J, Zhang Q, Li D, An Y, Kutryk MB. Hydroxybutyl Chitosan Polymer-Mediated 
CD133 Antibody Coating of Metallic Stents to Reduce Restenosis in a Porcine 
Model of Atherosclerosis. J Cardiovasc Pharmacol Ther 2014. 
 
Lin CS, Lue TF. Defining vascular stem cells. Stem Cells Dev 2013;22(7):1018-26. 
108. Lorson MA, Spate LD, Samuel MS, Murphy CN, Lorson CL, Prather RS, 
Wells KD. Disruption of the Survival Motor Neuron (SMN) gene in pigs using 
ssDNA. Transgenic Res 2011;20(6):1293-304. 
 
Luo Y, Li J, Liu Y, Lin L, Du Y, Li S, Yang H, Vajta G, Callesen H, Bolund L and 
others. High efficiency of BRCA1 knockout using rAAV-mediated gene targeting: 
developing a pig model for breast cancer. Transgenic Res 2011;20(5):975-88. 
 
Porcine in vitro and ex vivo models for cardiovascular biology 
87 
 
Lyubimov EV, Gotlieb AI. Smooth muscle cell growth in monolayer and aortic 
organ culture is promoted by a nonheparin binding endothelial cell-derived soluble 
factor/s. Cardiovasc Pathol 2004;13(3):139-45. 
 
Manfredi A, Marrocco E, Puppo A, Cesi G, Sommella A, Della Corte M, Rossi S, 
Giunti M, Craft CM, Bacci ML and others. Combined rod and cone transduction by 
adeno-associated virus 2/8. Hum Gene Ther 2013;24(12):982-92. 
 
Manzini S, Vargiolu A, Stehle IM, Bacci ML, Cerrito MG, Giovannoni R, Zannoni 
A, Bianco MR, Forni M, Donini P and others. Genetically modified pigs produced 
with a nonviral episomal vector. Proc Natl Acad Sci U S A 2006;103(47):17672-7. 
 
Mason C, Dunnill P. A brief definition of regenerative medicine. Regen Med 
2008;3(1):1-5. 
 
Mattiuzzo G, Takeuchi Y, Scobie L. Potential zoonotic infection of porcine 
endogenous retrovirus in xenotransplantation. Methods Mol Biol 2012;885:263-79. 
 
Mazzola S, Forni M, Albertini M, Bacci ML, Zannoni A, Gentilini F, Lavitrano M, 
Bach FH, Otterbein LE, Clement MG. Carbon monoxide pretreatment prevents 
respiratory derangement and ameliorates hyperacute endotoxic shock in pigs. 
FASEB J 2005;19(14):2045-7. 
 
McGonigle P, Ruggeri B. Animal models of human disease: challenges in enabling 
translation. Biochem Pharmacol 2014;87(1):162-71. 
 
Merrick AF, Shewring LD, Cunningham SA, Gustafsson K, Fabre JW. Organ culture 
of arteries for experimental studies of vascular endothelium in situ. Transpl Immunol 
1997;5(1):3-9. 
 
PhD thesis – Andrea Zaniboni, 2015 
88 
 
Murray IR, West CC, Hardy WR, James AW, Park TS, Nguyen A, Tawonsawatruk 
T, Lazzari L, Soo C, Péault B. Natural history of mesenchymal stem cells, from 
vessel walls to culture vessels. Cell Mol Life Sci 2014;71(8):1353-74. 
 
Mussolino C, della Corte M, Rossi S, Viola F, Di Vicino U, Marrocco E, Neglia S, 
Doria M, Testa F, Giovannoni R and others. AAV-mediated photoreceptor 
transduction of the pig cone-enriched retina. Gene Ther 2011;18(7):637-45. 
 
Niemann H, Kues WA. Application of transgenesis in livestock for agriculture and 
biomedicine. Anim Reprod Sci 2003;79(3-4):291-317. 
 
Noort WA, Oerlemans MI, Rozemuller H, Feyen D, Jaksani S, Stecher D, Naaijkens 
B, Martens AC, Bühring HJ, Doevendans PA and others. Human versus porcine 
mesenchymal stromal cells: phenotype, differentiation potential, immunomodulation 
and cardiac improvement after transplantation. J Cell Mol Med 2012;16(8):1827-39. 
 
Ostedgaard LS, Meyerholz DK, Chen JH, Pezzulo AA, Karp PH, Rokhlina T, Ernst 
SE, Hanfland RA, Reznikov LR, Ludwig PS and others. The ∆F508 mutation causes 
CFTR misprocessing and cystic fibrosis-like disease in pigs. Sci Transl Med 
2011;3(74):74ra24. 
 
Owen M, Friedenstein AJ. Stromal stem cells: marrow-derived osteogenic 
precursors. Ciba Found Symp 1988;136:42-60. 
 
Pacilli A, Pasquinelli G. Vascular wall resident progenitor cells: a review. Exp Cell 
Res 2009;315(6):901-14. 
 
Pankajakshan D, Kansal V, Agrawal DK. In vitro differentiation of bone marrow 
derived porcine mesenchymal stem cells to endothelial cells. J Tissue Eng Regen 
Med 2013;7(11):911-20. 
 
Porcine in vitro and ex vivo models for cardiovascular biology 
89 
 
Park KE, Telugu BP. Role of stem cells in large animal genetic engineering in the 
TALENs-CRISPR era. Reprod Fertil Dev 2013;26(1):65-73. 
 
Pérez de Prado A, Pérez-Martínez C, Cuellas Ramón C, Regueiro Purriños M, Diego 
Nieto A, Gonzalo-Orden JM, Molina Crisol M, Gómez Castel A, Duocastella Codina 
L, Fernández-Vázquez F. Safety and efficacy of different paclitaxel-eluting balloons 
in a porcine model. Rev Esp Cardiol (Engl Ed) 2014;67(6):456-62. 
 
Perkins LE. Preclinical models of restenosis and their application in the evaluation of 
drug-eluting stent systems. Vet Pathol 2010;47(1):58-76. 
 
Peterbauer-Scherb A, van Griensven M, Meinl A, Gabriel C, Redl H, Wolbank S. 
Isolation of pig bone marrow mesenchymal stem cells suitable for one-step 
procedures in chondrogenic regeneration. J Tissue Eng Regen Med 2010;4(6):485-
90. 
 
Petersen B, Niemann H. Advances in genetic modification of farm animals using 
zinc-finger nucleases (ZFN). Chromosome Res 2015. 
 
Petters RM, Alexander CA, Wells KD, Collins EB, Sommer JR, Blanton MR, Rojas 
G, Hao Y, Flowers WL, Banin E and others. Genetically engineered large animal 
model for studying cone photoreceptor survival and degeneration in retinitis 
pigmentosa. Nat Biotechnol 1997;15(10):965-70. 
 
Phelps CJ, Koike C, Vaught TD, Boone J, Wells KD, Chen SH, Ball S, Specht SM, 
Polejaeva IA, Monahan JA and others. Production of alpha 1,3-galactosyltransferase-
deficient pigs. Science 2003;299(5605):411-4. 
 
Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman 
MA, Simonetti DW, Craig S, Marshak DR. Multilineage potential of adult human 
mesenchymal stem cells. Science 1999;284(5411):143-7. 
 
PhD thesis – Andrea Zaniboni, 2015 
90 
 
Porras AM, Shanmuganayagam D, Meudt JJ, Krueger CG, Reed JD, Masters KS. 
Gene Expression Profiling of Valvular Interstitial Cells in Rapacz Familial 
Hypercholesterolemic Swine. Genom Data 2014;2:261-263. 
 
Prather RS, Lorson M, Ross JW, Whyte JJ, Walters E. Genetically engineered pig 
models for human diseases. Annu Rev Anim Biosci 2013;1:203-19. 
 
Prescott MF, McBride CH, Hasler-Rapacz J, Von Linden J, Rapacz J. Development 
of complex atherosclerotic lesions in pigs with inherited hyper-LDL cholesterolemia 
bearing mutant alleles for apolipoprotein B. Am J Pathol 1991;139(1):139-47. 
 
Psaltis PJ, Harbuzariu A, Delacroix S, Holroyd EW, Simari RD. Resident vascular 
progenitor cells--diverse origins, phenotype, and function. J Cardiovasc Transl Res 
2011;4(2):161-76. 
 
Rafieian-Kopaei M, Setorki M, Doudi M, Baradaran A, Nasri H. Atherosclerosis: 
process, indicators, risk factors and new hopes. Int J Prev Med 2014;5(8):927-46. 
 
Ranganath SH, Levy O, Inamdar MS, Karp JM. Harnessing the mesenchymal stem 
cell secretome for the treatment of cardiovascular disease. Cell Stem Cell 
2012;10(3):244-58. 
 
Renner S, Fehlings C, Herbach N, Hofmann A, von Waldthausen DC, Kessler B, 
Ulrichs K, Chodnevskaja I, Moskalenko V, Amselgruber W and others. Glucose 
intolerance and reduced proliferation of pancreatic beta-cells in transgenic pigs with 
impaired glucose-dependent insulinotropic polypeptide function. Diabetes 
2010;59(5):1228-38. 
 
Renner S, Braun-Reichhart C, Blutke A, Herbach N, Emrich D, Streckel E, Wünsch 
A, Kessler B, Kurome M, Bähr A and others. Permanent neonatal diabetes in 
INS(C94Y) transgenic pigs. Diabetes 2013;62(5):1505-11. 
 
Porcine in vitro and ex vivo models for cardiovascular biology 
91 
 
Ribeiro LA, Bacci ML, Seren E, Tamanini C, Forni M. Characterization and 
differential expression of vascular endothelial growth factor isoforms and receptors 
in swine corpus luteum throughout estrous cycle. Mol Reprod Dev 2007 a;74(2):163-
71. 
 
Ribeiro LA, Turba ME, Bernardini C, Zannoni A, Bacci ML, Forni M. Matrix 
metalloproteinases -2 and -9 in swine luteal tissue angiogenesis and angioregression. 
Vet Res Commun 2007 b;31 Suppl 1:193-6. 
 
Roberts RM, Telugu BP, Ezashi T. Induced pluripotent stem cells from swine (Sus 
scrofa): why they may prove to be important. Cell Cycle 2009;8(19):3078-81. 
 
Rogan MP, Reznikov LR, Pezzulo AA, Gansemer ND, Samuel M, Prather RS, 
Zabner J, Fredericks DC, McCray PB, Welsh MJ and others. Pigs and humans with 
cystic fibrosis have reduced insulin-like growth factor 1 (IGF1) levels at birth. Proc 
Natl Acad Sci U S A 2010;107(47):20571-5. 
 
Rogers CS, Abraham WM, Brogden KA, Engelhardt JF, Fisher JT, McCray PB, 
McLennan G, Meyerholz DK, Namati E, Ostedgaard LS and others. The porcine 
lung as a potential model for cystic fibrosis. Am J Physiol Lung Cell Mol Physiol 
2008 a;295(2):L240-63. 
 
Rogers CS, Stoltz DA, Meyerholz DK, Ostedgaard LS, Rokhlina T, Taft PJ, Rogan 
MP, Pezzulo AA, Karp PH, Itani OA and others. Disruption of the CFTR gene 
produces a model of cystic fibrosis in newborn pigs. Science 2008 
b;321(5897):1837-41. 
 
Ross JW, Fernandez de Castro JP, Zhao J, Samuel M, Walters E, Rios C, Bray-Ward 
P, Jones BW, Marc RE, Wang W and others. Generation of an inbred miniature pig 
model of retinitis pigmentosa. Invest Ophthalmol Vis Sci 2012;53(1):501-7. 
 
PhD thesis – Andrea Zaniboni, 2015 
92 
 
Rossignoli F, Caselli A, Grisendi G, Piccinno S, Burns JS, Murgia A, Veronesi E, 
Loschi P, Masini C, Conte P and others. Isolation, characterization, and transduction 
of endometrial decidual tissue multipotent mesenchymal stromal/stem cells from 
menstrual blood. Biomed Res Int 2013;2013:901821. 
 
Rozemuller H, Prins HJ, Naaijkens B, Staal J, Bühring HJ, Martens AC. Prospective 
isolation of mesenchymal stem cells from multiple mammalian species using cross-
reacting anti-human monoclonal antibodies. Stem Cells Dev 2010;19(12):1911-21. 
 
Russell WMS, Burch RL. The Principles of Humane Experimental Technique. 
Methuen, London, UK1959. 238 p. 
 
Sacchetti B, Funari A, Michienzi S, Di Cesare S, Piersanti S, Saggio I, Tagliafico E, 
Ferrari S, Robey PG, Riminucci M and others. Self-renewing osteoprogenitors in 
bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 
2007;131(2):324-36. 
 
Sachs DH, Galli C. Genetic manipulation in pigs. Curr Opin Organ Transplant 
2009;14(2):148-53. 
 
Saeki K, Matsumoto K, Kinoshita M, Suzuki I, Tasaka Y, Kano K, Taguchi Y, 
Mikami K, Hirabayashi M, Kashiwazaki N and others. Functional expression of a 
Delta12 fatty acid desaturase gene from spinach in transgenic pigs. Proc Natl Acad 
Sci U S A 2004;101(17):6361-6. 
 
Sánchez A, Schimmang T, García-Sancho J. Cell and tissue therapy in regenerative 
medicine. Adv Exp Med Biol 2012;741:89-102. 
 
Sandercock P, Roberts I. Systematic reviews of animal experiments. Lancet 
2002;360(9333):586. 
 
Porcine in vitro and ex vivo models for cardiovascular biology 
93 
 
Sangild PT, Thymann T, Schmidt M, Stoll B, Burrin DG, Buddington RK. Invited 
review: the preterm pig as a model in pediatric gastroenterology. J Anim Sci 
2013;91(10):4713-29. 
 
Sangild PT, Ney DM, Sigalet DL, Vegge A, Burrin D. Animal models of 
gastrointestinal and liver diseases. Animal models of infant short bowel syndrome: 
translational relevance and challenges. Am J Physiol Gastrointest Liver Physiol 
2014;307(12):G1147-68. 
 
Sato T, Iso Y, Uyama T, Kawachi K, Wakabayashi K, Omori Y, Soda T, Shoji M, 
Koba S, Yokoyama S and others. Coronary vein infusion of multipotent stromal cells 
from bone marrow preserves cardiac function in swine ischemic cardiomyopathy via 
enhanced neovascularization. Lab Invest 2011;91(4):553-64. 
 
Shi Y, O'Brien JE, Jr., Mannion JD, Morrison RC, Chung W, Fard A, Zalewski A. 
Remodeling of autologous saphenous vein grafts. The role of perivascular. 
Circulation 1997;95(12):2684-93. 
 
Simioniuc A, Campan M, Lionetti V, Marinelli M, Aquaro GD, Cavallini C, Valente 
S, Di Silvestre D, Cantoni S, Bernini F and others. Placental stem cells pre-treated 
with a hyaluronan mixed ester of butyric and retinoic acid to cure infarcted pig 
hearts: a multimodal study. Cardiovasc Res 2011;90(3):546-56. 
 
Singer NG, Caplan AI. Mesenchymal stem cells: mechanisms of inflammation. Annu 
Rev Pathol 2011;6:457-78. 
 
Singh J. The national centre for the replacement, refinement, and reduction of 
animals in research. J Pharmacol Pharmacother 2012;3(1):3. 
 
Smolenski RT, Forni M, Maccherini M, Bacci ML, Slominska EM, Wang H, 
Fornasari P, Giovannoni R, Simeone F, Zannoni A and others. Reduction of 
hyperacute rejection and protection of metabolism and function in hearts of human 
PhD thesis – Andrea Zaniboni, 2015 
94 
 
decay accelerating factor (hDAF)-expressing pigs. Cardiovasc Res 2007;73(1):143-
52. 
 
Stoltz DA, Meyerholz DK, Pezzulo AA, Ramachandran S, Rogan MP, Davis GJ, 
Hanfland RA, Wohlford-Lenane C, Dohrn CL, Bartlett JA and others. Cystic fibrosis 
pigs develop lung disease and exhibit defective bacterial eradication at birth. Sci 
Transl Med 2010;2(29):29ra31. 
 
Sun Z, Tee BC, Kennedy KS, Kennedy PM, Kim DG, Mallery SR, Fields HW. 
Scaffold-based delivery of autologous mesenchymal stem cells for mandibular 
distraction osteogenesis: preliminary studies in a porcine model. PLoS One 
2013;8(9):e74672. 
 
Suzuki Y, Yeung AC, Ikeno F. The representative porcine model for human 
cardiovascular disease. J Biomed Biotechnol 2011;2011:195483. 
 
Swindle MM, Makin A, Herron AJ, Clubb FJ, Frazier KS. Swine as models in 
biomedical research and toxicology testing. Vet Pathol 2012;49(2):344-56. 
 
Søndergaard LV, Ladewig J, Dagnæs-Hansen F, Herskin MS, Holm IE. Object 
recognition as a measure of memory in 1-2 years old transgenic minipigs carrying the 
APPsw mutation for Alzheimer's disease. Transgenic Res 2012;21(6):1341-8. 
 
Tang Z, Wang A, Yuan F, Yan Z, Liu B, Chu JS, Helms JA, Li S. Differentiation of 
multipotent vascular stem cells contributes to vascular diseases. Nat Commun 
2012;3:875. 
 
Templin C, Zweigerdt R, Schwanke K, Olmer R, Ghadri JR, Emmert MY, Müller E, 
Küest SM, Cohrs S, Schibli R and others. Transplantation and tracking of human-
induced pluripotent stem cells in a pig model of myocardial infarction: assessment of 
cell survival, engraftment, and distribution by hybrid single photon emission 
Porcine in vitro and ex vivo models for cardiovascular biology 
95 
 
computed tomography/computed tomography of sodium iodide symporter transgene 
expression. Circulation 2012;126(4):430-9. 
 
Tintut Y, Alfonso Z, Saini T, Radcliff K, Watson K, Boström K, Demer LL. 
Multilineage potential of cells from the artery wall. Circulation 2003;108(20):2505-
10. 
 
Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. Nat 
Rev Immunol 2008;8(9):726-36. 
 
Umeyama K, Watanabe M, Saito H, Kurome M, Tohi S, Matsunari H, Miki K, 
Nagashima H. Dominant-negative mutant hepatocyte nuclear factor 1alpha induces 
diabetes in transgenic-cloned pigs. Transgenic Res 2009;18(5):697-706. 
 
van der Spoel AG, Voogel AJ, Folkers A, Boer C, Bouwman RA. Comparison of 
noninvasive continuous arterial waveform analysis (Nexfin) with transthoracic 
Doppler echocardiography for monitoring of cardiac output. J Clin Anesth 
2012;24(4):304-9. 
 
Vargiolu A, Manzini S, de Cecco M, Bacci ML, Forni M, Galeati G, Cerrito MG, 
Busnelli M, Lavitrano M, Giovannoni R. In vitro production of multigene transgenic 
blastocysts via sperm-mediated gene transfer allows rapid screening of constructs to 
be used in xenotransplantation experiments. Transplant Proc 2010;42(6):2142-5. 
 
Vilahur G, Padro T, Badimon L. Atherosclerosis and thrombosis: insights from large 
animal models. J Biomed Biotechnol 2011;2011:907575. 
 
Wang X, Li Y, Han R, He C, Wang G, Wang J, Zheng J, Pei M, Wei L. 
Demineralized Bone Matrix Combined Bone Marrow Mesenchymal Stem Cells, 
Bone Morphogenetic Protein-2 and Transforming Growth Factor-β3 Gene Promoted 
Pig Cartilage Defect Repair. PLoS One 2014;9(12):e116061. 
 
PhD thesis – Andrea Zaniboni, 2015 
96 
 
Webster NL, Forni M, Bacci ML, Giovannoni R, Razzini R, Fantinati P, Zannoni A, 
Fusetti L, Dalprà L, Bianco MR and others. Multi-transgenic pigs expressing three 
fluorescent proteins produced with high efficiency by sperm mediated gene transfer. 
Mol Reprod Dev 2005;72(1):68-76. 
 
Wei J, Ouyang H, Wang Y, Pang D, Cong NX, Wang T, Leng B, Li D, Li X, Wu R 
and others. Characterization of a hypertriglyceridemic transgenic miniature pig 
model expressing human apolipoprotein CIII. FEBS J 2012;279(1):91-9. 
 
Weih S, Nickkholgh A, Kessler M, Frongia G, Hafezi M, Golriz M, Fard N, Holland-
Cunz S, Mehrabi A. Models of short bowel syndrome in pigs: a technical review. Eur 
Surg Res 2013;51(1-2):66-78. 
 
Wendler A, Wehling M. The translatability of animal models for clinical 
development: biomarkers and disease models. Curr Opin Pharmacol 2010;10(5):601-
6. 
 
West F, Stice S. Progress toward generating informative porcine biomedical models 
using induced pluripotent stem cells. Ann N Y Acad Sci 2011;1245:21-3. 
 
Wheeler DG, Joseph ME, Mahamud SD, Aurand WL, Mohler PJ, Pompili VJ, 
Dwyer KM, Nottle MB, Harrison SJ, d'Apice AJ and others. Transgenic swine: 
expression of human CD39 protects against myocardial injury. J Mol Cell Cardiol 
2012;52(5):958-61. 
 
White H, Thygesen K, Alpert JS, Jaffe A. Universal MI definition update for 
cardiovascular disease. Curr Cardiol Rep 2014;16(6):492. 
 
Whitelaw CB, Radcliffe PA, Ritchie WA, Carlisle A, Ellard FM, Pena RN, Rowe J, 
Clark AJ, King TJ, Mitrophanous KA. Efficient generation of transgenic pigs using 
equine infectious anaemia virus (EIAV) derived vector. FEBS Lett 2004;571(1-
3):233-6. 
Porcine in vitro and ex vivo models for cardiovascular biology 
97 
 
 
Whitworth KM, Lee K, Benne JA, Beaton BP, Spate LD, Murphy SL, Samuel MS, 
Mao J, O'Gorman C, Walters EM and others. Use of the CRISPR/Cas9 system to 
produce genetically engineered pigs from in vitro-derived oocytes and embryos. Biol 
Reprod 2014;91(3):78. 
 
Whyte JJ, Prather RS. Genetic modifications of pigs for medicine and agriculture. 
Mol Reprod Dev 2011;78(10-11):879-91. 
 
Whyte JJ, Samuel M, Mahan E, Padilla J, Simmons GH, Arce-Esquivel AA, Bender 
SB, Whitworth KM, Hao YH, Murphy CN and others. Vascular endothelium-
specific overexpression of human catalase in cloned pigs. Transgenic Res 
2011;20(5):989-1001. 
 
Whyte J, Laughlin MH. Placentation in the pig visualized by eGFP fluorescence in 
eNOS over-expressing cloned transgenic swine. Mol Reprod Dev 2010;77(7):565. 
190. Wolf E, Braun-Reichhart C, Streckel E, Renner S. Genetically engineered pig 
models for diabetes research. Transgenic Res 2014;23(1):27-38. 
 
Wright EJ, Farrell KA, Malik N, Kassem M, Lewis AL, Wallrapp C, Holt CM. 
Encapsulated glucagon-like peptide-1-producing mesenchymal stem cells have a 
beneficial effect on failing pig hearts. Stem Cells Transl Med 2012;1(10):759-69. 
 
Xie C, Ritchie RP, Huang H, Zhang J, Chen YE. Smooth muscle cell differentiation 
in vitro: models and underlying molecular mechanisms. Arterioscler Thromb Vasc 
Biol 2011;31(7):1485-94. 
 
Yang D, Wang CE, Zhao B, Li W, Ouyang Z, Liu Z, Yang H, Fan P, O'Neill A, Gu 
W and others. Expression of Huntington's disease protein results in apoptotic neurons 
in the brains of cloned transgenic pigs. Hum Mol Genet 2010;19(20):3983-94. 
 
PhD thesis – Andrea Zaniboni, 2015 
98 
 
Yang D, Yang H, Li W, Zhao B, Ouyang Z, Liu Z, Zhao Y, Fan N, Song J, Tian J 
and others. Generation of PPARγ mono-allelic knockout pigs via zinc-finger 
nucleases and nuclear transfer cloning. Cell Res 2011;21(6):979-82. 
 
Zaniboni A, Zannoni A, Bernardini C, De Cecco M, Bombardi C, Seren E, Forni M, 
Bacci ML. Development of a vessel organ culture system: characterisation of the 
method and implications for the reduction of animal experiments. Altern Lab Anim 
2013;41(4):259-69. 
 
Zaniboni A, Bernardini C, Alessandri M, Mangano C, Zannoni A, Bianchi F, Sarli G, 
Calzà L, Bacci ML, Forni M. Cells derived from porcine aorta tunica media show 
mesenchymal stromal-like cell properties in in vitro culture. Am J Physiol Cell 
Physiol 2014;306(4):C322-33. 
 
Zannoni A, Spinaci M, Bernardini C, Bacci ML, Seren E, Mattioli M, Forni M. 
DNase I activity in pig MII oocytes: implications in transgenesis. Reproduction 
2006;131(3):461-8. 
 
Zannoni A, Bernardini C, Rada T, Ribeiro LA, Forni M, Bacci ML. Prostaglandin 
F2-alpha receptor (FPr) expression on porcine corpus luteum microvascular 
endothelial cells (pCL-MVECs). Reprod Biol Endocrinol 2007;5:31. 
 
Zannoni A, Bernardini C, Gentilini F, Giunti M, Bacci ML, Forni M. Pulmonary 
kinetic expression of the endothelin system in a swine model of endotoxic shock. Vet 
Res Commun 2010;34 Suppl 1:S21-4. 
 
Zannoni A, Giunti M, Bernardini C, Gentilini F, Zaniboni A, Bacci ML, Forni M. 
Procalcitonin gene expression after LPS stimulation in the porcine animal model. 
Res Vet Sci 2012;93(2):921-7. 
 
Porcine in vitro and ex vivo models for cardiovascular biology 
99 
 
Zaragoza C, Gomez-Guerrero C, Martin-Ventura JL, Blanco-Colio L, Lavin B, 
Mallavia B, Tarin C, Mas S, Ortiz A, Egido J. Animal models of cardiovascular 
diseases. J Biomed Biotechnol 2011;2011:497841. 
 
Zheng B, Cao B, Crisan M, Sun B, Li G, Logar A, Yap S, Pollett JB, Drowley L, 
Cassino T and others. Prospective identification of myogenic endothelial cells in 
human skeletal muscle. Nat Biotechnol 2007;25(9):1025-34. 
 
Zheng Y, Liu Y, Zhang CM, Zhang HY, Li WH, Shi S, Le AD, Wang SL. Stem cells 
from deciduous tooth repair mandibular defect in swine. J Dent Res 2009;88(3):249-
54. 
